CHIR-99021 (CT99021) HCl

Catalog No.S2924

Molecular Weight(MW): 501.8

CHIR-99021 HCl (CT99021) is hydrochloride of CHIR-99021, which is a GSK-3α/β inhibitor with IC50 of 10 nM/6.7 nM; CHIR-99021 shows greater than 500-fold selectivity for GSK-3 versus its closest homologs Cdc2 and ERK2.

Cited by 101 Publications

Cell Stem Cell, 2019, 24(5):802-811

PubMed: 30880024 ( click the link to review the publication )

Cell, 2018, 174(2):406-421

PubMed: 29887375 ( click the link to review the publication )

Cell, 2018, 174(2):391-405

PubMed: 29937225 ( click the link to review the publication )

Cell Stem Cell, 2018, 22(3):369-383

PubMed: 29499153 ( click the link to review the publication )

Cell Stem Cell, 2017, 20(5):720-731

PubMed: 28343982 ( click the link to review the publication )

Cell Stem Cell, 2017, 20(4):518-532

PubMed: 28017796 ( click the link to review the publication )

Nature, 2015, 10.1038/nature14413

PubMed: 25945737 ( click the link to review the publication )

Cell Stem Cell, 2015, 10.1016/j.stem.2015.04.020

PubMed: ( click the link to review the publication )

Nat Biotechnol, 2014, 32(11):1121-33

PubMed: 25211370 ( click the link to review the publication )

Nature, 2013, 500(7461):222-6

PubMed: 23812591 ( click the link to review the publication )

Nat Commun, 2019, 10(1):928

PubMed: 30804331 ( click the link to review the publication )

Int J Cancer, 2019, 144(2):389-401

PubMed: 29978469 ( click the link to review the publication )

Mol Metab, 2019, 24:80-97

PubMed: 30930126 ( click the link to review the publication )

Front Physiol, 2019, 10:818

PubMed: 31316396 ( click the link to review the publication )

Mol Med Rep, 2019, 19(6):5440-5452

PubMed: 31059099 ( click the link to review the publication )

Exp Ther Med, 2019, 17(6):4547-4553

PubMed: 31186678 ( click the link to review the publication )

Mol Syst Biol, 2018, 14(3):e7858

PubMed: 29507054 ( click the link to review the publication )

Cell Rep, 2018, 25(9):2563-2576

PubMed: 30485820 ( click the link to review the publication )

Elife, 2018, 10.7554/eLife.40167

PubMed: 30561326 ( click the link to review the publication )

J Exp Clin Cancer Res, 2018, 37(1):22

PubMed: 29426364 ( click the link to review the publication )

Cell Death Dis, 2018, 9(6):598

PubMed: 29789524 ( click the link to review the publication )

Cell Chem Biol, 2018, 25(9):1095-1106

PubMed: 30251630 ( click the link to review the publication )

Biol Open, 2018, 7(9)

PubMed: 30135081 ( click the link to review the publication )

Methods Mol Biol, 2018, 1649:473-488

PubMed: 29130217 ( click the link to review the publication )
Curr Protoc Hum Genet, 2018, 10.1002/cphg.64

PubMed: 29979824 ( click the link to review the publication )

Methods Mol Biol, 2018, 1733:127-136

PubMed: 29435928 ( click the link to review the publication )

ACS Appl Mater Interfaces, 2017, 9(31):25929-25940

PubMed: 28718622 ( click the link to review the publication )

Biomater Sci, 2017, 5(8):1567-1578

PubMed: 28715029 ( click the link to review the publication )

Stem Cell Res Ther, 2017, 8(1):156

PubMed: 28676082 ( click the link to review the publication )

Sci Rep, 2017, 7(1):9490

PubMed: 28842634 ( click the link to review the publication )

Biofabrication, 2017, 9(2):025007

PubMed: 28287080 ( click the link to review the publication )

JCI Insight, 2017, 2(18)

PubMed: 28931764 ( click the link to review the publication )

Stem Cells, 2016, 34(7):1765-75

PubMed: 26946228 ( click the link to review the publication )

Sci Rep, 2016, 6:23817

PubMed: 27026509 ( click the link to review the publication )

PLoS One, 2016, 11(8):e0161508

PubMed: 27560518 ( click the link to review the publication )

Exp Ther Med, 2016, 12(6):3851-3858

PubMed: 28101169 ( click the link to review the publication )

Methods Mol Biol, 2016, 1353:181-90

PubMed: 25523811 ( click the link to review the publication )

Methods Mol Biol, 2016, 1480:153-65

PubMed: 27659983 ( click the link to review the publication )

Nat Commun, 2015, 6:7413

PubMed: 26172574 ( click the link to review the publication )

Dev Cell, 2015, 32(6):667-77

PubMed: 25805134 ( click the link to review the publication )

Stem Cell Res, 2015, 10.1016/j.scr.2015.05.004

PubMed: ( click the link to review the publication )

Stem Cells, 2015, 33(3):686-98

PubMed: ( click the link to review the publication )

Exp Mol Med, 2015, 47:e143

PubMed: 25721419 ( click the link to review the publication )

Exp Mol Med, 2015, 47:e143

PubMed: 25721419 ( click the link to review the publication )

Mol Neurobiol, 2015, 10.1007/s12035-014-9084-z

PubMed: 25663198 ( click the link to review the publication )

J Thromb Haemost, 2015, 10.1111/jth.12954

PubMed: 25858425 ( click the link to review the publication )

J Biol Chem, 2015, 290(9):5592-605

PubMed: ( click the link to review the publication )

Stem Cells Dev, 2015, 10.1089/scd.2014.0422

PubMed: 25751301 ( click the link to review the publication )
Cell Transplant, 2015, 10.3727/096368914X685762

PubMed: 25562386 ( click the link to review the publication )

Biol Open, 2015, 4(1):48-61

PubMed: ( click the link to review the publication )

J Physiol, 2015, 593(5):1147-57

PubMed: ( click the link to review the publication )

Sci Rep, 2015, 5:9718

PubMed: 25864432 ( click the link to review the publication )

Methods Mol Biol, 2015, 10.1007/7651_2015_220

PubMed: 25762297 ( click the link to review the publication )

Methods Mol Biol, 2015, 1264:453-63

PubMed: 25631034 ( click the link to review the publication )

Cell Biology International Reports, 2015, 10.1002/cbi3.10019

PubMed: ( click the link to review the publication )

Circ Res, 2014, 115(6):556-66

PubMed: 25015077 ( click the link to review the publication )

Proc Natl Acad Sci USA, 2014, 111(12):4484-9

PubMed: 24623855 ( click the link to review the publication )

Biomaterials, 2014, 35(5):1367-77

PubMed: 24268663 ( click the link to review the publication )

Stem Cell Rep, 2014, 3(4):594-605

PubMed: 25358788 ( click the link to review the publication )

Stem Cell Rep, 2014, 3(5):804-16

PubMed: 25418725 ( click the link to review the publication )

Stem Cell Rep, 2014, 3(5):804-16

PubMed: 25418725 ( click the link to review the publication )

Acta Biomater, 2014, 10(2):604-12

PubMed: 24200714 ( click the link to review the publication )

Protein Cell, 2014, 5(1):59-68

PubMed: 24474197 ( click the link to review the publication )

Mol Cancer Ther, 2014, 13(4):812-22

PubMed: 24552772 ( click the link to review the publication )

Mol Cell Proteomics, 2014, 13(4):990-1007

PubMed: 24482122 ( click the link to review the publication )

J Biol Chem, 2014, 289(47):32628-38

PubMed: ( click the link to review the publication )

J Biol Chem, 2014, 10.1074/jbc.M114.580076

PubMed: 25301940 ( click the link to review the publication )

J Biol Chem, 2014, 289(20):14341-50

PubMed: 24692544 ( click the link to review the publication )

Am J Cancer Res, 2014, 6(6):724-735

PubMed: ( click the link to review the publication )

Mol Pharmacol, 2014, 83(5):1020-9

PubMed: 23448715 ( click the link to review the publication )

Stem Cells Dev, 2014, 23(14):1688-703

PubMed: 24641164 ( click the link to review the publication )

Stem Cells Dev, 2014, 10.1089/scd.2014.0011

PubMed: 24805295 ( click the link to review the publication )
Stem Cells Dev, 2014, 23(14):1688-703

PubMed: 24641164 ( click the link to review the publication )

Exp Cell Res, 2014, 328(2):351-60

PubMed: 25172557 ( click the link to review the publication )

PLoS One, 2014, 9(12):e115854

PubMed: 25541965 ( click the link to review the publication )

PLoS One, 2014, 9(1):e85089

PubMed: 24465482 ( click the link to review the publication )

PLoS One, 2014, 9(4):e92304

PubMed: 24743237 ( click the link to review the publication )

Exp Biol Med, 2014, 239(10):1390-402

PubMed: 24951472 ( click the link to review the publication )

Theriogenology, 2014, 82(2):283-93

PubMed: 24853281 ( click the link to review the publication )

Cell Reprogram, 2014, 10.1089/cell.2014.0028

PubMed: 25084370 ( click the link to review the publication )

J Huazhong Univ Sci Technolog Med Sci, 2014, 34(2):151-6

PubMed: 24710923 ( click the link to review the publication )

University of GOTHENBURG, 2014, 5495

PubMed: ( click the link to review the publication )

Sci Rep, 2014, 4:6425

PubMed: 25236849 ( click the link to review the publication )

Methods Mol Biol, 2014, 10.1007/7651_2014_172

PubMed: 25520292 ( click the link to review the publication )

Nat Commun, 2013, 4:2628

PubMed: 24165455 ( click the link to review the publication )

Proc Natl Acad Sci USA, 2013, 110(52):E5039-48

PubMed: 24248365 ( click the link to review the publication )

Stem Cell Res, 2013, 12(2):364-375

PubMed: 24365601 ( click the link to review the publication )

Stem Cell Rep, 2013, 1(4):360-10

PubMed: 24319670 ( click the link to review the publication )

Antioxid Redox Sign, 2013, 20(18):2907-22

PubMed: 24219064 ( click the link to review the publication )

Mol Cancer Ther, 2013, 13(2):454-67

PubMed: 24282277 ( click the link to review the publication )

Biochim Biophys Acta, 2013, 1830(8):4102-16

PubMed: 23628704 ( click the link to review the publication )

J Biol Chem, 2013, 288(49):35500-10

PubMed: 24165128 ( click the link to review the publication )

Leuk Res, 2013, 37(10):1329-40

PubMed: 23867056 ( click the link to review the publication )

Nat Protoc, 2012, 8(1):162-75

PubMed: 23257984 ( click the link to review the publication )

Proc Natl Acad Sci USA, 2012, 109(27):E1848-57

PubMed: 22645348 ( click the link to review the publication )

Stem Cells, 2012, 30(9):1863-74

PubMed: 22761013 ( click the link to review the publication )
Carcinogenesis, 2012, 33(3):529-37

PubMed: 22201186 ( click the link to review the publication )

J Biol Chem, 2012, 287(2):893-904

PubMed: 22102280 ( click the link to review the publication )

PLoS One, 2012, 7(10):e47312

PubMed: 23077590 ( click the link to review the publication )

BMC Dev Biol, 2012, 12:21

PubMed: 22846383 ( click the link to review the publication )

Bachelor of Science, 2012, East China Normal University

PubMed: ( click the link to review the publication )

Purity & Quality Control

Choose Selective GSK-3 Inhibitors

Biological Activity

Description

Targets

GSK-3β ^[1] (Cell-free assay)	GSK-3α ^[1] (Cell-free assay)
6.7 nM	10 nM

In vitro

CHIR-99021 shows greater than 500-fold selectivity for GSK-3 versus its closest homologs CDC2 and ERK2, as well as other protein kinases. Furthermore, CHIR-99021 shows only weak binding to a panel of 22 pharmacologically relevant receptors and little inhibitory activity against a panel of 23 nonkinase enzymes. CHIR-99021 induces the activation of glycogen synthase (GS) in insulin receptor-expressing CHO-IR cells with EC50 of 0.763 μM. ^[1] In addition to simulating the actions of insulin, inhibition of GSK-3 by CHIR-99021 (3 μM) increases free cytosolic β-catenin by 1.9-fold, mimicking the canonical Wnt signaling pathway in 3T3-L1 preadipocytes. During any of the first 3 days of differentiation, CHIR-99021 treatment inhibits the preadipocyte differentiation with IC50 of 0.3 μM by blocking induction of CCAAT/enhancer-binding protein α (C/EBPα) and peroxisome proliferator-activated receptor γ (PPARγ). ^[2] Unlike lithium chloride and AR-A014418, CHIR-99021 treatment does not reduce the viability of INS-1E cells even at high concentrations. Instead, CHIR-99021 robustly increases the rate of proliferation of INS-1E cells in a dose-dependent manner, and significantly inhibits INS-E cell death induced by high glucose and high palmitate in a concentration-dependent manner. CHIR-99021 promotes primary beta cell replication in isolated rat islets at concentrations as low as 1 μM, with 2-3 fold increase of cell replication at 5 μM of CHIR-99021 treatment. ^[3]

Cell Data

Cell Lines	Assay Type	Concentration	Incubation Time	Formulation	Activity Description	PMID
3T3-L1	MVrGeY5kfGmxbjDBd5NigQ>?	MlPSN{DPxE1?	MV20JIg>	MkexSG1UVw>?	MXXJcohq[mm2czDwdoVi\Gmyb3P5eIUh\GmoZnXy[Y51cWG2aX;u	M2W3NVEzODV3MkCw
insulin receptor–expressing CHO-IR	NGPQSolHfW6ldHnvckBCe3OjeR?=	NXT4c4J2PTByIH7N	MojQN\|AhdWmw	NWTQSZNzTE2VTx?=	M3WzVWFkfGm4YYTld{BIdHmlb3flckBUgW62aHHz[UApT1Nr	Mn3vNVI3ODZ2OUe=
H4IIE	MVTGeY5kfGmxbjDBd5NigQ>?	M37FOlExKM7:TR?=	M1v2blI1KGh?	NYW4VI1LTE2VTx?=	MYfS[Yd2dGG2ZYOg{tIu[2G2ZX7pckBi[3Srdnn0fUBidmRiVFnSSUBkd262YXnubY5oKHC{b33veIVzKGGldHn2bZR6	MoG4NVU{PTBzOUW=
Oct4/Sox2/Klf4-infected MEFs	NWPoWJc6TnWwY4Tpc44hSXO\|YYm=	NV\6WG5OOTBizszN	M2T4e\|I5KGR?	MkPYSG1UVw>?	MnLRVJJwdW:2ZYOgUWVHeyC{ZYDyc4dz[W2vaX7nJHRz[W6\|ZIXj[YQh[nliT3P0OEwhW2:6MjygZY5lKEuuZkS=	MmOwNVk5OzlyNUW=
Sca-1+ HPC	M3jKe2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7	NG\mbFkzKM7:TR?=	NETqS2g3KGR?	NH6wNIVFVVOR	MVvTfY5memerc4TpZ4FtdHlicILvcY91\XNiU3PhMVEsyqCKUFOgdJJwdGmoZYLheIlwdiCjbnSgZ49td267IH\vdo1ifGmxbjD0c4dmfGincjD3bZRpKEWJRh?=	M{HNR\|IyPjJ2M{S4
HMC1.2	MmLkS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?	M13xbFMxKM7:TR?=	NGnO[Gk4OiCq	NFTyWldFVVOR	M2fpcHJm\HWlZYOgZ4VtdCC\|dYL2bZZidA>?	MXiyNlA{QTNyMR?=
Endothelial cell(EC)	NWTaRWFpTnWwY4Tpc44hSXO\|YYm=	M1\zSFMh\|ryP		M1XVTGROW09?	MYTQdo9ud3SnczDlcoRwfGinbHnhcEBk\WyuIDjFR{kh\GmoZnXy[Y51cWG2aX;u	NYDhNWNPOjJyNUKwNFY>
PANC1	MVHBdI9xfG:\|aYOgRZN{[Xl?	Ml6yxsA2KM7:TR?=	M3LF[\|czKGh?	M2m1SGROW09?	M3zwRXRzcWepZYLzJIFvKGGyb4D0c5Rq[yC{ZYPwc45{\Q>?	MVGyNlIxOTF6Nh?=
INS-1E	Mm\vSpVv[3Srb36gRZN{[Xl?	MkH2Nk42KM7:TR?=	MUeyOEBp	NUHuPHozTE2VTx?=	M3;6Nmlv\HWlZYOgZUBz\WS3Y4Tpc44hd2ZiTmCxJI93\XKneIDy[ZN{cW:w	MUOyNlQzPzdyNB?=
hiPSC-NPs	M1;KTGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7	NHHydVQ{6oDLzszN	M2G4WFczKGh?	MYrEUXNQ	M2\qUWlv[3KnYYPld{Bk\WyuIIDyc4xq\mW{YYTpc47DqA>?	M4\nW\|IzPjR{Nki3
platelets	M3:zcGZ2dmO2aX;uJGF{e2G7	M33rflExKM7:TR?=	MUCxOUBucW5?	NF;yUXJFVVOR	MnPtTY5kemWjc3XzJJRpem:vYnnuMY1m\GmjdHXkJJBt[XSnbHX0JIFo\3KnZ3H0bY9vKGGwZDDBWHAhe2WlcnX0bY9v	MmDiNlMzOzl6N{e=
DN3	MoD2SpVv[3Srb36gRZN{[Xl?	NEj2T5MyOCEQvF2=	NYfqb5p1QTZiaB?=	MXzEUXNQ	NV;qdFZbUW6lcnXhd4V{KGOnbHyg[IV3\WyxcH3lcpQh[W6mIIDyc4xq\mW{YYTpc44>	NFjMNZkzOzV{Nkm4PS=>
embryonic stem cells (ESC)	MljkSpVv[3Srb36gRZN{[Xl?	NWDYbW51OyEEtV2=	NEHQ[4wyOSCm	MkDySG1UVw>?	M{To[HBzd22xdHXzJJNmdGZvcnXu[ZdidCCxZjDuZeOwfmVvdInw[UBud3W\|ZTDlcYJzgW:waXOgd5RmdSClZXzsd{ApTVOFKR?=	M37OZ\|I{QDR\|M{Gy
H460	Mnn4S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?	NWfz[\|N3PSEEtV2=	NWXZWGF2OjRiaB?=	NHjRb3pFVVOR	NUXkSoRFWHKxbX;0[ZMh[2WubDDwdo9tcW[ncnH0bY9v	M{TKeVI1OzZ5Nki4
H157	MojMS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?	NUHIT5ZQPSEEtV2=	MXKyOEBp	MortSG1UVw>?	M361VHBzd22xdHXzJINmdGxicILvcIln\XKjdHnvci=>	MWCyOFM3PzZ6OB?=
H460	NYH6SohySXCxcITvd4l{KEG\|c3H5	MoXaOUDDvU1?	Mmn2NlQhcA>?	M2m3bWROW09?	MlL3RZR1\W63YYTld{Bk\WyuIHHwc5B1d3Orcx?=	M2LiU\|I1OzZ5Nki4
H157	M33GcmFxd3C2b4Ppd{BCe3OjeR?=	Mn[zOUDDvU1?	MV2yOEBp	NXLEOGVTTE2VTx?=	NHL2cVBFd2W\|IH7veEB{cWewaX\pZ4FvfGy7IHHm[oVkfCCjcH;weI9{cXN?	MV[yOFM3PzZ6OB?=
A549	Mnr4RZBweHSxc3nzJGF{e2G7	NFThVFU2KML3TR?=	NI\h[VUzPCCq	M3PpNWROW09?	MYPJcoNz\WG\|ZYOgZ4VtdCCjcH;weI9{cXN?	NWLQb3FqOjR\|Nke2PFg>
Neural progenitor cells	MWXGeY5kfGmxbjDBd5NigQ>?	NG\WW3M{KM7:TR?=	MVKxNEBl	MX3EUXNQ	MWLJcoR2[2W\|IHflcoVz[XSrb36gc4YhdmW3cnHsJJBzd2enbnn0c5Ih[2WubIO=	NXX6V\|Z5OjR4M{iwN\|Q>
ES-D3	M1HjZmN6fG:2b4jpZ{BCe3OjeR?=	NXr6OWJPOTEEoN88US=>	NGS1PXo{KGR?	Mn73SG1UVw>?	M{TlW2lv\HWlZYOgcY9l\XKjdHWgZ5l1d3SxeHnjbZR6KHerdHigTWM2OCCxZjC0Mlkh\|ryP	MoLKNlQ4Pzl\|NkW=
ES-CCE	NHHkTGFEgXSxdH;4bYMhSXO\|YYm=	MkHDNVDDqM7:TR?=	MUmzJIQ>	MnLYSG1UVw>?	NWXCeZdXUW6mdXPld{Bud2SncnH0[UBkgXSxdH;4bYNqfHl?	M1ziPVI1Pzd7M{[1
ES-D3	MUDGeY5kfGmxbjDBd5NigQ>?	MWO1xsDPxE1?	MXqzJIQ>	M2SxcmROW09?	M2i5N3N1em:wZ3z5JIlv\HWlZYOgeIhmKGGldHn2bZR6KG:oIGfueE9j\XSjLXPheIVvcW5icHH0bJdigQ>?	NHHXV44zPDd5OUO2OS=>
ES-CCE	MmnnSpVv[3Srb36gRZN{[Xl?	MYm1xsDPxE1?	M{nm[VMh\A>?	M3:yVGROW09?	MWLTeJJwdmeueTDpcoR2[2W\|IITo[UBi[3Srdnn0fUBw\iCZboSvZoV1[S2lYYTlcolvKHCjdHj3ZZk>	M1vWOlI1Pzd7M{[1
SW982	MVnHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?				M3;VOmlEPTB;MD6yNVQyPiEQvF2=	MVnTRW5ITVJ?
GCT	M122NWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7				M4nGXmlEPTB;MD6zNFY4OiEQvF2=	NH7rRY1USU6JRWK=
769-P	NWq3VYx{T3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=				NEGzV4dKSzVyPUCuOVg1QTlizszN	MXLTRW5ITVJ?
LOXIMVI	MYfHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?				MlXMTWM2OD1yLkW4PFMzKM7:TR?=	MljGV2FPT0WU
D-336MG	NUHsZ4hDT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=				MXTJR\|UxRTBwOES2NkDPxE1?	NVfWOHpXW0GQR1XS
S-117	NIjkXpJIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=				MnzKTWM2OD1yLkmyNVMyKM7:TR?=	M2O4THNCVkeHUh?=
D-247MG	NFjNU3dIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=				MmPXTWM2OD1yLkm0PFUzKM7:TR?=	NVXYb4tMW0GQR1XS
TYK-nu	M3rZfmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7				NYG5U5Y6UUN3ME2xMlA4QTF{IN88US=>	NUSyR5ExW0GQR1XS
A498	Ml\uS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?				MW\JR\|UxRTFwM{C0Olkh\|ryP	NIXOVZFUSU6JRWK=
BCPAP	NFW3TpdIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=				MV3JR\|UxRTFwNk[4PVgh\|ryP	Mn3OV2FPT0WU
KYSE-180	Ml;xS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?				Mn;xTWM2OD1zLkeyO\|g5KM7:TR?=	NHvTR41USU6JRWK=
MIA-PaCa-2	NHPVbmRIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=				M2S5VWlEPTB;MT63OVk4PyEQvF2=	MYnTRW5ITVJ?
HCC1395	NGDjVVNIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=				Ml3MTWM2OD1zLke4Nlc{KM7:TR?=	NFTUT49USU6JRWK=
RS4-11	MYjHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?				Mo\pTWM2OD1zLkm1OFE2KM7:TR?=	MVfTRW5ITVJ?
NCI-H2122	NE\XXlVIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=				M1vFUGlEPTB;Mj6yO\|Y5PCEQvF2=	NGDmV4dUSU6JRWK=
SNU-423	MmG0S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?				MnXtTWM2OD1{LkS5O\|g4KM7:TR?=	M4jkT3NCVkeHUh?=
SK-LMS-1	NHf3bHJIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=				NWTR[XR4UUN3ME2yMlY1OTJ6IN88US=>	NILSU5pUSU6JRWK=
RPMI-7951	NIjYWXRIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=				NF\IO3dKSzVyPUKuO\|AyQTNizszN	M4\zbnNCVkeHUh?=
COLO-829	NIfUOYpIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=				M4\OWWlEPTB;Mj63OlU1KM7:TR?=	NEHHcGNUSU6JRWK=
SCC-9	NYP2ZY9qT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=				M37MfWlEPTB;Mj65OVQ5PSEQvF2=	NEL1UVhUSU6JRWK=
A704	MnPDS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?				M2rW[2lEPTB;Mz6wPFEzKM7:TR?=	NEe1PGRUSU6JRWK=
HOP-62	NXrtSoFwT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=				MULJR\|UxRTNwM{[wOVQh\|ryP	M1fmSnNCVkeHUh?=
HCC1569	NYLN[\|Q{T3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=				M2HiWWlEPTB;Mz60PFMxPSEQvF2=	NIDxTY1USU6JRWK=
A172	MUnHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?				NID1O5JKSzVyPUOuO\|U1QThizszN	NH\GTmdUSU6JRWK=
MOLT-16	Mn70S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?				Mn;JTWM2OD1\|Lki4OVU3KM7:TR?=	NXnpXnM5W0GQR1XS
TE-15	MnzIS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?				M1LQZmlEPTB;Mz65OVM1OyEQvF2=	MkDrV2FPT0WU
OE19	NUjWTZoxT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=				NVLsbYZHUUN3ME2zMlk3PDVzIN88US=>	NFTTVJFUSU6JRWK=
MHH-ES-1	NFrNSGFIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=				NGPyPZdKSzVyPUSuNFQ2PDVizszN	NFvHUmhUSU6JRWK=
NKM-1	NV7oXJFIT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=				M{CwZmlEPTB;ND6xN\|k4OSEQvF2=	MnW3V2FPT0WU
RCC10RGB	MkLXS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?				MV3JR\|UxRTRwMkm0O\|kh\|ryP	MmfWV2FPT0WU
BxPC-3	MXLHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?				MYPJR\|UxRTRwN{CzPVEh\|ryP	NFXLSpRUSU6JRWK=
ALL-PO	M{LHO2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7				MmTVTWM2OD12LkizPFU5KM7:TR?=	MmTKV2FPT0WU
SK-OV-3	MXvHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?				M3XufGlEPTB;ND65PVM1KM7:TR?=	M4PjNnNCVkeHUh?=
SW1710	M3TPdWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7				NEjFPY9KSzVyPUWuOFI1PTZizszN	Ml3jV2FPT0WU
NCI-H2452	MW\Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?				NFfkZ5hKSzVyPUWuOFU3OjhizszN	NGjrb2JUSU6JRWK=
D-392MG	MYDHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?				NIjBdJhKSzVyPUWuOFkyPDVizszN	NVXJSpRkW0GQR1XS
LB2518-MEL	MVnHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?				M2\JT2lEPTB;NT63NlYzPyEQvF2=	Mnq2V2FPT0WU
BL-41	NGnFTVRIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=				NFXEUmxKSzVyPUWuPFEzPjZizszN	M3TXR3NCVkeHUh?=
WM-115	NHfmTXlIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=				NEnHe\|NKSzVyPUWuPFE2ODlizszN	MVrTRW5ITVJ?
SK-MEL-2	M2r6Z2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7				NVjjeHZpUUN3ME22MlM5OzR2IN88US=>	M3LJU3NCVkeHUh?=
CGTH-W-1	NH[4R5FIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=				NH\jV49KSzVyPU[uOFE4KM7:TR?=	M1zUUHNCVkeHUh?=
BB65-RCC	NE\2[JRIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=				MXLJR\|UxRTZwNUOxPVUh\|ryP	M3;EUnNCVkeHUh?=
CAL-85-1	MVjHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?				MnuwTWM2OD14Lk[wPVM3KM7:TR?=	NETHeYNUSU6JRWK=
RT-112	NGm5OVRIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=				MoDMTWM2OD15LkG2OFU3KM7:TR?=	M3q2OHNCVkeHUh?=
MC116	Mn3uS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?				MnTXTWM2OD15LkK4OlkyKM7:TR?=	NVSxc3RHW0GQR1XS
G-361	NETnUnhIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=				NY\r[5lyUUN3ME23MlQ3PTZzIN88US=>	MYTTRW5ITVJ?
SW1417	M4HWbmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7				NWflbndKUUN3ME23MlY1PTh2IN88US=>	MUfTRW5ITVJ?
MV-4-11	NVrFZXJQT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=				NVe2eIRCUUN3ME24MlU1OzB2IN88US=>	M2\aeXNCVkeHUh?=
CAL-72	NYHyWZR3T3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=				M3LW[2lEPTB;OD63OlEyOyEQvF2=	MnvnV2FPT0WU
MKN28	NWrSXlRFT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=				NGXqeHlKSzVyPUiuPFg2OTZizszN	MofUV2FPT0WU
MEG-01	M2\KUmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7				NW\IWHQyUUN3ME24Mlk6ODR\|IN88US=>	NVfrfIhKW0GQR1XS
ACHN	MknNS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?				NWjqRnZjUUN3ME25MlMxPTR4IN88US=>	NIK0T\|JUSU6JRWK=
NCI-H1755	MmHVS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?				NWHGfWgzUUN3ME25MlM6QTh4IN88US=>	NXKyOHkxW0GQR1XS
NCI-H64	M2m0Z2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7				MXnJR\|UxRTlwNEKyOVUh\|ryP	MonQV2FPT0WU
COLO-205	M{\Lc2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7				NW\KXJRpUUN3ME25MlQ{QDJzIN88US=>	M1HTOHNCVkeHUh?=
CTV-1	M4i0VGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7				NX3LPXd2UUN3ME25MlQ{QDl2IN88US=>	MkS2V2FPT0WU
U-2-OS	NIfzWWpIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=				MlXKTWM2OD17LkS1NFA3KM7:TR?=	MYTTRW5ITVJ?
LB996-RCC	M3rpTmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7				NUjJOWU4UUN3ME25MlUzOzl5IN88US=>	MUHTRW5ITVJ?
SK-N-DZ	M164fWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7				NF\mcIJKSzVyPUmuOlU4PDJizszN	NH\m[nFUSU6JRWK=
EFM-19	M2rJNmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7				MXvJR\|UxRTlwN{W1OlYh\|ryP	MXHTRW5ITVJ?
DBTRG-05MG	NWOyWVBTT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=				Mk\3TWM2OD17Lke3O\|ch\|ryP	NGPs[4lUSU6JRWK=
U-118-MG	M1yzZmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7				MoG1TWM2OD17Lkm0OFQ1KM7:TR?=	MorIV2FPT0WU
LB1047-RCC	MmXMS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?				M4j4SGlEPTB;OT65PVc6QCEQvF2=	NWH1[FJmW0GQR1XS
NCI-H28	M3T1eGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7				MmKzTWM2OD1zMD60OFE{KM7:TR?=	MoLoV2FPT0WU
MZ2-MEL	MX\Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?				NELPb\|NKSzVyPUGwMlQ3PzdizszN	M3\Lb3NCVkeHUh?=
M059J	NXjvT3N7T3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=				MVrJR\|UxRTFyLk[xNFIh\|ryP	M4L3XHNCVkeHUh?=
HT-3	M1rzcmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7				MUXJR\|UxRTFyLk[xO\|kh\|ryP	NETONIFUSU6JRWK=
SNU-387	NX\pWnVRT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=				MoXwTWM2OD1zMD63NlM2KM7:TR?=	MkHlV2FPT0WU
NCI-H526	M2q5cmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7				NHrLNGhKSzVyPUGxMlE{PjVizszN	NWLQdGZHW0GQR1XS
HEL	MXvHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?				NWfGTo9IUUN3ME2xNU43PTd7IN88US=>	NYXOWGZrW0GQR1XS
PA-1	NGfZOmtIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=				MXvJR\|UxRTFzLkmzJO69VQ>?	MWTTRW5ITVJ?
PC-14	MX7Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?				MX\JR\|UxRTF{LkOyOEDPxE1?	MnjMV2FPT0WU
C8166	Mn3GS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?				NIDEUGxKSzVyPUGzMlI{OThizszN	NGLaT\|RUSU6JRWK=
NCI-H82	NUfrNGttT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=				NH;UT3NKSzVyPUGzMlI6ODlizszN	MlPVV2FPT0WU
DSH1	M4ToNGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7				NIPhO4hKSzVyPUGzMlM5PzlizszN	MoLvV2FPT0WU
T98G	NGTrTm1Iem:5dHigTY5pcWKrdHnvckBCe3OjeR?=				MmDCTWM2OD1zMz60O\|E4KM7:TR?=	NH\6XmRUSU6JRWK=
KU812	MWrHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?				MUXJR\|UxRTF\|LkWxO\|Uh\|ryP	M134SHNCVkeHUh?=
SW48	MmD2S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?				MX\JR\|UxRTF\|LkeyOlUh\|ryP	NFHh[HJUSU6JRWK=
MEL-HO	MmnRS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?				M{myfmlEPTB;MUOuPFgzQSEQvF2=	MWXTRW5ITVJ?
SF539	NFj6WlVIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=				NIDNdllKSzVyPUG0MlAyOTZizszN	Mlz2V2FPT0WU
NB1	M{K3fmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7				NFe2SmpKSzVyPUG0MlE6OzVizszN	NXXEOI9xW0GQR1XS
ST486	NX3ST\|VXT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=				NX\NVGR1UUN3ME2xOE4zOjVzIN88US=>	MnTtV2FPT0WU
LoVo	NV;LNm1DT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=				NYT2[4VVUUN3ME2xOU4zPjV7IN88US=>	M1jSWnNCVkeHUh?=
NH-12	NV7xU401T3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=				NGfxfmZKSzVyPUG2MlAxQTdizszN	NVPPTmhDW0GQR1XS
CCRF-CEM	NGDMfmlIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=				NGXJe4pKSzVyPUG2MlY4ODJizszN	NESy[mhUSU6JRWK=
Daudi	MoHsS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?				MluwTWM2OD1zNz62NVQ6KM7:TR?=	NXHrfYdGW0GQR1XS
SIMA	Mli1S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?				MlPWTWM2OD1zNz65NVE5KM7:TR?=	MnXZV2FPT0WU
8305C	M4joXWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7				NUjTNmZVUUN3ME2xPE42OzB3IN88US=>	MnjHV2FPT0WU
EM-2	M2G1[mdzd3e2aDDJcohq[mm2aX;uJGF{e2G7				M1;1cWlEPTB;MUiuOlI1QCEQvF2=	NWeyRo9WW0GQR1XS
SNU-449	Mm\VS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?				MX\JR\|UxRTF6LkexOUDPxE1?	NVrH[I1vW0GQR1XS
A101D	NVHVPZhsT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=				NYLs[\|Q1UUN3ME2xPU4zPDNizszN	M4nqWXNCVkeHUh?=
MHH-NB-11	MmrYS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?				MmfaTWM2OD1zOT61N\|QzKM7:TR?=	MYHTRW5ITVJ?
Becker	M2riV2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7				MULJR\|UxRTJyLkG3O\|ch\|ryP	NH;HclJUSU6JRWK=
NCI-H727	NGn5SZVIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=				M3XN[2lEPTB;MkCuNlE3QSEQvF2=	Mo\ZV2FPT0WU
HCC1187	MoG1S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?				MoTWTWM2OD1{MD6zOVg6KM7:TR?=	Ml\zV2FPT0WU
KYSE-450	NHfwT3NIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=				MV\JR\|UxRTJzLkWzOVQh\|ryP	NWLnV5huW0GQR1XS
SK-MEL-28	MkHaS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?				NYXRVGtEUUN3ME2yNU43QDZ\|IN88US=>	NXLiRpJzW0GQR1XS
BPH-1	NIrxfYhIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=				MmDRTWM2OD1{MT63NFM2KM7:TR?=	MWLTRW5ITVJ?
EoL-1-	NGO3WGdIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=				M3y0[GlEPTB;MkGuPFM5PSEQvF2=	MmfSV2FPT0WU
TGBC24TKB	Ml3ES5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?				MlnqTWM2OD1{MT64PVU4KM7:TR?=	NIPQe5JUSU6JRWK=
KARPAS-299	NHjyN3RIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=				MnexTWM2OD1{Mj6xPVU1KM7:TR?=	M4joNnNCVkeHUh?=
SW684	NYXlOphRT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=				M3zqcmlEPTB;MkKuNlg2QCEQvF2=	MXHTRW5ITVJ?
RXF393	M4rhbWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7				NF;RdoZKSzVyPUKyMlYxPjhizszN	MVHTRW5ITVJ?
LS-513	MX\Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?				MV;JR\|UxRTJ{Lk[xPVIh\|ryP	NFLqd\|NUSU6JRWK=
KURAMOCHI	MnHGS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?				Ml:yTWM2OD1{Mj63NFY6KM7:TR?=	M{LWV3NCVkeHUh?=
GI-1	MkD0S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?				MlnpTWM2OD1{Mj63PFQyKM7:TR?=	MXLTRW5ITVJ?
M14	Mmf0S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?				M1T2PGlEPTB;MkOuNVE{OiEQvF2=	M2PJWnNCVkeHUh?=
REH	NVPnfIU{T3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=				MUXJR\|UxRTJ\|LkG2PVkh\|ryP	NHHQeYRUSU6JRWK=
K5	NVvVTGFlT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=				NWjHVohwUUN3ME2yN{42PDh4IN88US=>	NXTlWIFOW0GQR1XS
PANC-10-05	MWHHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?				NVzsd4dqUUN3ME2yOE4xQDl6IN88US=>	NF3KXmtUSU6JRWK=
HMV-II	NH7MUGNIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=				MXrJR\|UxRTJ2LkKxOlMh\|ryP	NEjZWJNUSU6JRWK=
NCI-H1963	MW\Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?				MnrUTWM2OD1{ND6yPFM6KM7:TR?=	MX7TRW5ITVJ?
LU-139	Ml;3S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?				M2n1[mlEPTB;MkSuPFM2KM7:TR?=	NVq3W2lPW0GQR1XS
KASUMI-1	MVjHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?				M3rEU2lEPTB;MkSuPVMzQCEQvF2=	NYHPOVRFW0GQR1XS
RO82-W-1	MlyxS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?				NX3m[5N6UUN3ME2yOk44Ozd5IN88US=>	NXjjV4lvW0GQR1XS
NCI-H1770	NEHteGhIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=				MUTJR\|UxRTJ4Lki5PFYh\|ryP	NFzHeppUSU6JRWK=
SNG-M	NWOx[5FKT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=				NFy0TW1KSzVyPUK3MlIzPzFizszN	MX\TRW5ITVJ?
KLE	NGjyVnNIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=				MlfUTWM2OD1{Nz6yOVY2KM7:TR?=	M4HudXNCVkeHUh?=
NCI-H2170	NVTzRVBkT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=				MXrJR\|UxRTJ5LkWyPFIh\|ryP	NVLpSHVTW0GQR1XS
COLO-792	Mn\TS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?				MmjUTWM2OD1{Nz63O\|I5KM7:TR?=	M3WwXXNCVkeHUh?=
ES8	MWHHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?				NWDze45tUUN3ME2yO{44QDF2IN88US=>	NXfNXG83W0GQR1XS
MC-CAR	NFj6OmdIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=				MXXJR\|UxRTJ5Lke5NFch\|ryP	Mo\GV2FPT0WU
SU-DHL-1	NFLLWmlIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=				NYPsU45EUUN3ME2yO{46PDd2IN88US=>	NWHR[nB5W0GQR1XS
OAW-28	NETFdZpIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=				MnrqTWM2OD1{OD6wNFUzKM7:TR?=	NVe0Z\|R7W0GQR1XS
C32	NFXE[YlIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=				NIPs[pZKSzVyPUK4MlA5OjZizszN	Mlz1V2FPT0WU
SW872	NEH2UpNIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=				MlLUTWM2OD1{OD61N\|I3KM7:TR?=	NFj6eoFUSU6JRWK=
JiyoyeP-2003	NVH0TIxIT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=				NGXYcFVKSzVyPUK5MlY4OTlizszN	M{TaUnNCVkeHUh?=
A204	NX\EcmFRT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=				MWTJR\|UxRTJ7Lk[4Nlgh\|ryP	NXPhWVJQW0GQR1XS
IST-MES1	M1ztXWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7				MkfkTWM2OD1{OT63NFkzKM7:TR?=	MoPHV2FPT0WU
LCLC-103H	NIW4PW5Iem:5dHigTY5pcWKrdHnvckBCe3OjeR?=				NXKycWRTUUN3ME2zNE4zODV7IN88US=>	M4DtbXNCVkeHUh?=
CAKI-1	MXfHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?				MkLzTWM2OD1\|MD6yOlU3KM7:TR?=	MXPTRW5ITVJ?
NALM-6	MVzHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?				MnnOTWM2OD1\|MD60PVY2KM7:TR?=	NV3mdHE6W0GQR1XS
SK-MM-2	Mn\iS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?				NXe3bYRPUUN3ME2zNE46Pzl{IN88US=>	M3L1SnNCVkeHUh?=
LB373-MEL-D	NFvyNFZIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=				NYTOWIdNUUN3ME2zNU4xODR5IN88US=>	Ml\yV2FPT0WU
CAS-1	M{\FNGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7				Ml7KTWM2OD1\|MT63OlY2KM7:TR?=	NEe4SYhUSU6JRWK=
KNS-42	Mmn1S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?				NWGzVGoyUUN3ME2zNU45PjZ{IN88US=>	Mk\QV2FPT0WU
SW948	MoOxS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?				MXzJR\|UxRTN{Lke1OFgh\|ryP	MVXTRW5ITVJ?
HCC1143	MV\Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?				NEjUOHBKSzVyPUOyMlc6PzlizszN	M4TXZnNCVkeHUh?=
NCI-H1648	NYHNUI5zT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=				MnvoTWM2OD1\|Mj64OFY4KM7:TR?=	M4rpPXNCVkeHUh?=
RVH-421	MV\Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?				NVvD[2RyUUN3ME2zN{4yPjhizszN	MnnrV2FPT0WU
KU-19-19	NEi4dIZIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=				NEDHfHhKSzVyPUOzMlc2OzRizszN	MYfTRW5ITVJ?
PFSK-1	M1PCN2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7				MnHFTWM2OD1\|ND65NlQyKM7:TR?=	MlWwV2FPT0WU
TK10	NHvxW3NIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=				M37nNWlEPTB;M{WuNVMzOiEQvF2=	MVfTRW5ITVJ?
IGROV-1	Ml7kS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?				NHfXeXNKSzVyPUO1MlM1OTZizszN	M2rKO3NCVkeHUh?=
EFE-184	M1Wxcmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7				NGHqcWlKSzVyPUO1MlkyPyEQvF2=	NHLm[YpUSU6JRWK=
8505C	NWHyS4tTT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=				NVj3eWQ2UUN3ME2zOU46Ojl2IN88US=>	MX\TRW5ITVJ?
SK-UT-1	NFS2NmNIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=				MUPJR\|UxRTN4LkOzN\|Eh\|ryP	MVzTRW5ITVJ?
MKN1	NEHmS4VIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=				Mo[zTWM2OD1\|Nj64OFQ1KM7:TR?=	NYe3O2FKW0GQR1XS
no-10	NV\DTFVjT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=				NFrsepFKSzVyPUO4MlEzQTRizszN	NFTLe5RUSU6JRWK=
HT-144	MUDHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?				M3XUcWlEPTB;M{iuNlU4PSEQvF2=	M2LJTnNCVkeHUh?=
CMK	M2TFU2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7				NWq0VXVOUUN3ME2zPE41OTZ{IN88US=>	MnXnV2FPT0WU
KM12	NGDGdGNIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=				M3f3dWlEPTB;M{iuOVk6QCEQvF2=	MmHrV2FPT0WU
HCC2218	NUjSTG1TT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=				MkfKTWM2OD12MD61PFQ6KM7:TR?=	M4r2XHNCVkeHUh?=
BE-13	Mn36S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?				MmT6TWM2OD12MT60OFc{KM7:TR?=	MULTRW5ITVJ?
SK-CO-1	MYDHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?				M3LBU2lEPTB;NEGuO\|c2PSEQvF2=	NH\EUJVUSU6JRWK=
MPP-89	MWnHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?				MXHJR\|UxRTRzLkmyNVEh\|ryP	NX\Kb\|c3W0GQR1XS
NY	Mmi1S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?				MXLJR\|UxRTR{LkG4NFEh\|ryP	M2XwdHNCVkeHUh?=
IST-MEL1	NF63bnZIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=				NGTpeFFKSzVyPUSyMlY6OzhizszN	NHvzS\|VUSU6JRWK=
HCT-116	MVfHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?				MW\JR\|UxRTR\|LkKwPVkh\|ryP	M3j5NnNCVkeHUh?=
LB831-BLC	MoHMS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?				M17PbGlEPTB;NEOuOlk4KM7:TR?=	MkfXV2FPT0WU
TE-8	NIHvXlhIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=				NV3uUZZ7UUN3ME20N{44QDl3IN88US=>	MULTRW5ITVJ?
SR	M2DMVGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7				MYXJR\|UxRTR\|Lki2O\|Mh\|ryP	NYLYPYRWW0GQR1XS
ESS-1	MnPiS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?				NV\HdYo4UUN3ME20OE4zODZ{IN88US=>	MWLTRW5ITVJ?
KYSE-270	MWDHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?				MoTYTWM2OD12NT6wOFM4KM7:TR?=	MoXRV2FPT0WU
H4	NY\lTnFDT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=				MWLJR\|UxRTR3LkOyPVYh\|ryP	MWXTRW5ITVJ?
COLO-800	M4L4SGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7				MW\JR\|UxRTR3LkW4PVgh\|ryP	NILIXZhUSU6JRWK=
Ramos-2G6-4C10	MVnHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?				MkPPTWM2OD12Nj6wO\|U2KM7:TR?=	NXv4SGtFW0GQR1XS
no-11	NELrSmdIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=				NVH5W3BiUUN3ME20Ok4zODNzIN88US=>	NVXTeFJ3W0GQR1XS
UACC-62	MVPHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?				MnjVTWM2OD12Nj64OlA5KM7:TR?=	NHnkb29USU6JRWK=
D-542MG	NY[5S4s1T3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=				NH3wXJdKSzVyPUS3MlQ2QDlizszN	M{n1bHNCVkeHUh?=
NCI-H747	NXuybYd1T3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=				MnvRTWM2OD12Nz63NlY1KM7:TR?=	M{fKeXNCVkeHUh?=
HCC2998	NXvPOlNHT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=				MVXJR\|UxRTR6LkK5PFIh\|ryP	M1LxUnNCVkeHUh?=
SNB75	MUjHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?				MXzJR\|UxRTR6LkSxNVgh\|ryP	NELYXlZUSU6JRWK=
COR-L105	NFvvfWRIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=				M{S5Z2lEPTB;NEiuPVc{KM7:TR?=	NVTseohTW0GQR1XS
SNU-C1	M2P0fWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7				M3vSSWlEPTB;NEmuN\|IxPyEQvF2=	MXHTRW5ITVJ?
LC4-1	MWPHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?				NGT1RnhKSzVyPUS5Mlg6OTJizszN	M1Hs[3NCVkeHUh?=
KS-1	M3;pSmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7				Mn7STWM2OD13MD6yNlI2KM7:TR?=	MXzTRW5ITVJ?
NCI-H1793	NH7sepZIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=				NFfVZ2ZKSzVyPUWxMlI{OSEQvF2=	NIr6ZZhUSU6JRWK=
NCI-H1650	NVfpd2tIT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=				M1nMXmlEPTB;NUGuOVg1QSEQvF2=	MVjTRW5ITVJ?
MCF7	M1vzWWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7				NGTPZolKSzVyPUWxMlc2PTRizszN	NFjkXXBUSU6JRWK=
SK-N-AS	MnrpS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?				Ml6xTWM2OD13MT64NlgyKM7:TR?=	NH\mVWpUSU6JRWK=
SW837	NFXoe\|lIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=				M3;Uc2lEPTB;NUGuPVc5PSEQvF2=	M1jtXXNCVkeHUh?=
DB	NF3ROWdIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=				MXzJR\|UxRTVzLkm4OVUh\|ryP	NGfnfGFUSU6JRWK=
CESS	NWq3dVNqT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=				M1f3emlEPTB;NUKuNVQ2KM7:TR?=	M4fZ[3NCVkeHUh?=
CHP-126	M4XTXmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7				MVjJR\|UxRTV\|LkWxOlkh\|ryP	M1TKSnNCVkeHUh?=
COLO-824	M2e1S2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7				MmTsTWM2OD13Mz62PVc3KM7:TR?=	NU[xOoNYW0GQR1XS
MG-63	M4\X[Gdzd3e2aDDJcohq[mm2aX;uJGF{e2G7				NVTxUGI1UUN3ME21N{46OzhzIN88US=>	NFHwXVZUSU6JRWK=
KGN	M3rpTGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7				MVjJR\|UxRTV\|Lkm1PUDPxE1?	M4TWNnNCVkeHUh?=
697	MojtS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?				MnTaTWM2OD13ND6xOVU2KM7:TR?=	NF3vc4JUSU6JRWK=
MC-IXC	Mn7BS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?				MoLMTWM2OD13ND60N\|Y1KM7:TR?=	NF36XpRUSU6JRWK=
A375	MU\Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?				NHeyZ2hKSzVyPUW0MlgxPTlizszN	NYjUSWdbW0GQR1XS
LXF-289	MoSyS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?				MmjWTWM2OD13NT61NFY3KM7:TR?=	M3rWTXNCVkeHUh?=
ES6	M174fmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7				MnG0TWM2OD13NT64PFk6KM7:TR?=	NVv5RXJ1W0GQR1XS
DV-90	NYnRfmZpT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=				NF3IW4RKSzVyPUW1Mlg6OTdizszN	NEHteI5USU6JRWK=
RCM-1	MWLHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?				MmDETWM2OD13Nj6wNFc5KM7:TR?=	MYDTRW5ITVJ?
NCI-H2405	MVLHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?				M1XnfWlEPTB;NU[uNVY6OyEQvF2=	NVPYUXhGW0GQR1XS
DoTc2-4510	NX\QNI9YT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=				NWS0bHlSUUN3ME21Ok43ODV5IN88US=>	MWDTRW5ITVJ?
RPMI-8866	NH\FTolIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=				NH7BcldKSzVyPUW3MlI1OTJizszN	NFrldI9USU6JRWK=
BV-173	NEX2bJdIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=				M3zjXGlEPTB;NUeuOVE1OiEQvF2=	MlzFV2FPT0WU
LCLC-97TM1	NIS5eFlIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=				MlzMTWM2OD13OT6wOVU{KM7:TR?=	M3;HZnNCVkeHUh?=
HT-1376	NHyzRoZIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=				M{GyZWlEPTB;NUmuNFkzOSEQvF2=	MlviV2FPT0WU
ACN	MUfHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?				NX\NVpUxUUN3ME21PU4yPTh5IN88US=>	MULTRW5ITVJ?
LU-134-A	Mli1S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?				M2LqSGlEPTB;NUmuOlAyPiEQvF2=	MoDQV2FPT0WU
SiHa	M3LuVGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7				MYfJR\|UxRTV7Lk[0PFch\|ryP	NYPXRWd5W0GQR1XS
EKVX	Mm\5S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?				NY\mNGNnUUN3ME22NU41QTV6IN88US=>	MmfrV2FPT0WU
NMC-G1	NYjoS2s6T3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=				NF7ETGxKSzVyPU[xMlkzPDJizszN	NH\U[4FUSU6JRWK=
NCI-H1734	MVjHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?				NI\PO4JKSzVyPU[xMlk3PjNizszN	MWjTRW5ITVJ?
K-562	M1TiS2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7				NEfUcnJKSzVyPU[yMlI1PTJizszN	MlH3V2FPT0WU
T-24	NGHkfZpIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=				M{e4fmlEPTB;NkKuO\|EzPiEQvF2=	M4XzUHNCVkeHUh?=
SCH	MXvHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?				NGLobXdKSzVyPU[0MlI{PTFizszN	NGC0OIpUSU6JRWK=
AN3-CA	NXzSfmVXT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=				MkLiTWM2OD14ND6zNFM2KM7:TR?=	NVXJc5FUW0GQR1XS
MFE-296	MVTHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?				MUPJR\|UxRTZ2LkS0O\|Mh\|ryP	MYfTRW5ITVJ?
HuCCT1	MnLtS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?				NH3kWGJKSzVyPU[3MlA{PzRizszN	MoTJV2FPT0WU
NCI-H1703	MWXHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?				MnXCTWM2OD14OD6xNVcyKM7:TR?=	NXnOfGF7W0GQR1XS
C-4-II	MmOwS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?				NWXPd4xZUUN3ME22PU4{PjB5IN88US=>	NUXONWJ5W0GQR1XS
NCI-H2342	NIrEcpVIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=				M1jDTmlEPTB;NkmuN\|k3OSEQvF2=	NFO2WGtUSU6JRWK=
Hs-578-T	M{HI[Gdzd3e2aDDJcohq[mm2aX;uJGF{e2G7				NF3Sc\|BKSzVyPUewMlMh\|ryP	MWjTRW5ITVJ?
HCC1806	MV;Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?				MmK4TWM2OD15MT60OVg4KM7:TR?=	NWDsWJpoW0GQR1XS
EW-16	M1fXeGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7				Mme4TWM2OD15MT63OFE2KM7:TR?=	MlTSV2FPT0WU
KALS-1	NEL0bGZIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=				M4TENWlEPTB;N{OuOVQ4PSEQvF2=	M4PEXnNCVkeHUh?=
RT4	NV;seHlkT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=				NWfUOHplUUN3ME23N{42PzR{IN88US=>	NFPY[lJUSU6JRWK=
LS-411N	NXvUUXh1T3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=				Mn\CTWM2OD15ND6yOVI5KM7:TR?=	MmixV2FPT0WU
SK-MEL-1	NXriV4xZT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=				Mk\mTWM2OD15NT64NFE6KM7:TR?=	NYL4PHhKW0GQR1XS
8-MG-BA	MkPKS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?				MU\JR\|UxRTd4LkGwPVYh\|ryP	MlOxV2FPT0WU
HSC-3	NIr5e4xIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=				M3;WZWlEPTB;N{euNFI5OiEQvF2=	M3nVbnNCVkeHUh?=
NB6	NULxc5E1T3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=				NHfmPWFKSzVyPUe4MlEzQTlizszN	NU\tTHp5W0GQR1XS
PANC-03-27	MkjPS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?				NY\WRpJ4UUN3ME23PE41OzVizszN	Ml3oV2FPT0WU
KP-N-YS	M1rUU2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7				MknSTWM2OD15OD61PFc5KM7:TR?=	M4Xy[XNCVkeHUh?=
SF295	MlPPS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?				NXm5R3lSUUN3ME23PU46PTV\|IN88US=>	NHv5Sm5USU6JRWK=
HCE-T	M2DNNmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7				NWTubHAzUUN3ME24NE4yPTh6IN88US=>	MXHTRW5ITVJ?
KYSE-410	NHz2TW9Iem:5dHigTY5pcWKrdHnvckBCe3OjeR?=				NFrFUFFKSzVyPUiwMlI5PTdizszN	NGD3NWxUSU6JRWK=
NB12	MlfKS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?				M33mV2lEPTB;OECuPVM3QSEQvF2=	M3LBW3NCVkeHUh?=
NCI-H661	NF34bYpIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=				NWL5cId1UUN3ME24NU4{PDRizszN	NESwTllUSU6JRWK=
NCI-H1417	MXLHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?				MVXJR\|UxRThzLkSzOlgh\|ryP	MVfTRW5ITVJ?
KMOE-2	NUTOdHpCT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=				NES2dnlKSzVyPUixMlg2OzFizszN	MmqyV2FPT0WU
SW1573	NWC4WY9KT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=				NHO1XWVKSzVyPUiyMlU5QTNizszN	NW[5SGtzW0GQR1XS
BFTC-905	NX;wPJdGT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=				MV7JR\|UxRTh2LkCxO\|Ih\|ryP	M2TaNHNCVkeHUh?=
SBC-1	M{LRVmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7				NYrYcoVQUUN3ME24OE4xOjB6IN88US=>	MX3TRW5ITVJ?
MDA-MB-175-VII	MWnHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?				M4eyXWlEPTB;OEWuO\|QzPiEQvF2=	NVmxNVNLW0GQR1XS
TE-12	MoPTS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?				NXzzNmRyUUN3ME24PU4{PzRzIN88US=>	MV3TRW5ITVJ?
NCI-H650	M{TTTGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7				MkfETWM2OD16OT64O\|I1KM7:TR?=	M1W3S3NCVkeHUh?=
C-33-A	NGjFdG5Iem:5dHigTY5pcWKrdHnvckBCe3OjeR?=				M2nRV2lEPTB;OUCuOVQh\|ryP	NITDRVVUSU6JRWK=
MZ7-mel	NWjnRpBvT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=				NX\0cpNQUUN3ME25NU4zPjd4IN88US=>	NG\3dFJUSU6JRWK=
BOKU	NFrP[YVIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=				MV;JR\|UxRTl{Lk[5OVch\|ryP	NF3UNmlUSU6JRWK=
CAL-33	MVHHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?				NXnvfphiUUN3ME25N{4xPjBzIN88US=>	M1voVHNCVkeHUh?=
23132-87	NILIZ49Iem:5dHigTY5pcWKrdHnvckBCe3OjeR?=				NEPncYVKSzVyPUmzMlE3QCEQvF2=	MXHTRW5ITVJ?
J82	M2G2cGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7				NGfOe\|JKSzVyPUmzMlc5OTFizszN	M1P2NXNCVkeHUh?=
MZ1-PC	MX7Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?				M1nUTmlEPTB;OUSuOVk5PCEQvF2=	NWfGTHZRW0GQR1XS
MEL-JUSO	Mmm2S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?				MV7JR\|UxRTl2Lkm1OEDPxE1?	MWXTRW5ITVJ?
RMG-I	MY\Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?				MkW3TWM2OD17NT6xNFczKM7:TR?=	MWHTRW5ITVJ?
A2058	M4TTO2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7				MWPJR\|UxRTl3LkS2NVch\|ryP	MnrGV2FPT0WU
Caov-4	MXHHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?				MnnZTWM2OD17NT62PFUh\|ryP	NF3ibVlUSU6JRWK=
OS-RC-2	NVTGT4VpT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=				MmHvTWM2OD17Nz60OlEh\|ryP	NWnERXplW0GQR1XS
MKN7	MnLqS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?				NV\6cWViUUN3ME25O{44PDN7IN88US=>	MmGzV2FPT0WU
U-698-M	MVnHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?				NW\seYhZUUN3ME25PE46PDh7IN88US=>	MUPTRW5ITVJ?
PC-3	NF\oZ\|FIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=				NWHXWFRbUUN3ME25PU4xPTZ2IN88US=>	MlL6V2FPT0WU
NCI-H292	M3TSfGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7				MWrJR\|UxRTl7LkOwNFQh\|ryP	M2Hjc3NCVkeHUh?=
IGR-1	Mme4S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?				NFXwd4pKSzVyPUm5MlMyOTlizszN	M2PnU3NCVkeHUh?=
Mewo	MmnYS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?				MYDJR\|UxRTl7LkW2NFMh\|ryP	Mlm3V2FPT0WU
LU-65	NVzNNJhwT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=				M{e2eGlEPTB;MUCxMlA5OSEQvF2=	MV7TRW5ITVJ?
Saos-2	NGniTYRIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=				M2XwbmlEPTB;MUCxMlQ{PyEQvF2=	NWSxW4dPW0GQR1XS
TE-11	M4nCZmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7				NHjYWZBKSzVyPUGwNU44OjRizszN	NEDkVo1USU6JRWK=
SK-MES-1	MVPHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?				NHjnUnlKSzVyPUGwNU44PjJizszN	NVvIc4ZjW0GQR1XS
KE-37	MWPHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?				NIDzTFJKSzVyPUGwNk46PSEQvF2=	NFjnXplUSU6JRWK=
MKN45	Mme1S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?				NUnZcpF4UUN3ME2xNFMvPTh2IN88US=>	MnXHV2FPT0WU
UM-UC-3	NH35fWVIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=				NW\SPY85UUN3ME2xNFMvQDR{IN88US=>	Mk[xV2FPT0WU
SNU-C2B	NYXINHB7T3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=				Mn;TTWM2OD1zMEWuNFI{KM7:TR?=	NVHudYlwW0GQR1XS
RPMI-8226	M1y4Zmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7				NECwOZFKSzVyPUGwOk43PzhizszN	NXTjOFF1W0GQR1XS
PANC-08-13	MlX5S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?				M4DkSmlEPTB;MUC2Mlg2KM7:TR?=	MWPTRW5ITVJ?
NCI-H23	NVGzWGdxT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=				NF63e2dKSzVyPUGwPE4{PTdizszN	M3f6fHNCVkeHUh?=
HOP-92	MlrOS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?				M2L1XmlEPTB;MUC4MlQ4PSEQvF2=	NF;vXI5USU6JRWK=
FTC-133	NHnwXZBIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=				NYftenFrUUN3ME2xNFgvPDh6IN88US=>	M1HzfXNCVkeHUh?=
D-263MG	M{O0VWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7				NYHtd4JRUUN3ME2xNFgvQTZzIN88US=>	MVrTRW5ITVJ?
DU-145	M3fldGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7				MX3JR\|UxRTFyOT65OFUh\|ryP	Mn7oV2FPT0WU
A253	MV3Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?				M3rXcGlEPTB;MUGwMlQ4QSEQvF2=	MXfTRW5ITVJ?
HCT-15	Mk\VS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?				Ml;zTWM2OD1zMUCuOlYyKM7:TR?=	NHjCZm9USU6JRWK=
WSU-NHL	NGDXWmhIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=				M1Pxb2lEPTB;MUGyMlAyKM7:TR?=	NF\Ld3ZUSU6JRWK=
U031	NGjwU5VIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=				MVvJR\|UxRTFzMj6wOlUh\|ryP	MkO0V2FPT0WU
MDA-MB-157	M3HRUGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7				NXiye3VpUUN3ME2xNVIvPDlizszN	NIrBSnlUSU6JRWK=
NEC8	NFzzWXRIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=				M1v0VGlEPTB;MUGyMlYzPCEQvF2=	MnPlV2FPT0WU
SIG-M5	NWn6UIZoT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=				M4rXRmlEPTB;MUGzMlEzPSEQvF2=	M1LCcnNCVkeHUh?=
786-0	NE\F[mtIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=				MW\JR\|UxRTFzMz60OVMh\|ryP	MV\TRW5ITVJ?
DMS-273	MWDHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?				NHLFZXVKSzVyPUGxOU43OTdizszN	MVXTRW5ITVJ?
Calu-6	NHrHVIpIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=				Mn\zTWM2OD1zMU[uO\|k5KM7:TR?=	NXz5VFZMW0GQR1XS
HCC1599	NUewVHRtT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=				NWPGNVI6UUN3ME2xNVcvOTV4IN88US=>	NVfCUph7W0GQR1XS
OVCAR-8	MlPPS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?				M3XVU2lEPTB;MUG3MlY3QCEQvF2=	NYrWXI13W0GQR1XS
ATN-1	MU\Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?				M4DtSWlEPTB;MUG3MlgzQCEQvF2=	MlXYV2FPT0WU
RKO	MmTES5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?				NUTPSGFoUUN3ME2xNVcvQDl6IN88US=>	NX3VR\|E4W0GQR1XS
SKG-IIIa	NYfXPWtRT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=				M4\VWmlEPTB;MUG4MlEyPiEQvF2=	MlruV2FPT0WU
SUP-T1	M{DJfWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7				NVH5[VFSUUN3ME2xNVgvQTV4IN88US=>	NHyy[pNUSU6JRWK=
KNS-81-FD	M1L3emdzd3e2aDDJcohq[mm2aX;uJGF{e2G7				MoLxTWM2OD1zMUmuOFE4KM7:TR?=	NXPQSHlEW0GQR1XS
OVCAR-3	M3P1[mdzd3e2aDDJcohq[mm2aX;uJGF{e2G7				Ml3pTWM2OD1zMUmuPVE2KM7:TR?=	MnvOV2FPT0WU
NCI-N87	NYjabYZQT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=				NGi5UGJKSzVyPUGyNU4xPDRizszN	MUTTRW5ITVJ?
HuP-T4	NIXwcYxIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=				NXnPTFUxUUN3ME2xNlEvPTVizszN	NH7OZolUSU6JRWK=
KYSE-140	NWHpNmo1T3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=				NUT5[IQyUUN3ME2xNlIvOTRzIN88US=>	M3nVd3NCVkeHUh?=
HAL-01	M33JNmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7				NYLnZVN3UUN3ME2xNlIvPDl7IN88US=>	NF7DTpRUSU6JRWK=
HT-29	Mn;qS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?				NF6yfHNKSzVyPUGyNk44PzhizszN	MoH0V2FPT0WU
OPM-2	MULHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?				M1uyVGlEPTB;MUKzMlE4PiEQvF2=	MVvTRW5ITVJ?
SW1463	Mo\3S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?				NXPFU2dHUUN3ME2xNlQvODd5IN88US=>	M3zIXXNCVkeHUh?=
NCI-H2087	NXHaOmk1T3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=				NIHRfI5KSzVyPUGyOE4zQDNizszN	NWLUOll3W0GQR1XS
UMC-11	M2LNWWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7				M1vpfmlEPTB;MUK2MlA{QCEQvF2=	MmDxV2FPT0WU
EB-3	MU\Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?				M3;jW2lEPTB;MUK3MlAyOyEQvF2=	MVXTRW5ITVJ?
HEC-1	MmPhS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?				NE\XNXJKSzVyPUGyPU4yQThizszN	MWXTRW5ITVJ?
LU-99A	MVzHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?				MYPJR\|UxRTF{OT65N\|Eh\|ryP	M1rDd3NCVkeHUh?=
VMRC-RCZ	NWDR[4oxT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=				MULJR\|UxRTF\|MD6zO\|Uh\|ryP	MUnTRW5ITVJ?
MFH-ino	MkP6S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?				NXK2NJZrUUN3ME2xN\|EvOTF2IN88US=>	NYjFVoVYW0GQR1XS
HT-1080	NE\1U4dIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=				MUDJR\|UxRTF\|Mj6yNFQh\|ryP	MlTaV2FPT0WU
CTB-1	M4izTWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7				M2PEcWlEPTB;MUOyMlg6PyEQvF2=	M1nHOnNCVkeHUh?=
Capan-2	NH\tcmtIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=				NH;4SmRKSzVyPUGzN{46PzVizszN	MnL1V2FPT0WU
BB30-HNC	Ml7MS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?				MnPsTWM2OD1zM{SuNVE3KM7:TR?=	NH3ES4NUSU6JRWK=
CP50-MEL-B	Mnn4S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?				NH\ZW4RKSzVyPUGzOE4zKM7:TR?=	MlW1V2FPT0WU
JEG-3	NXXafJUyT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=				M1\RbWlEPTB;MUO0MlM2QSEQvF2=	NGLGNldUSU6JRWK=
NCI-H1437	MkPaS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?				NUXSZWlXUUN3ME2xN\|QvPTlizszN	MoPtV2FPT0WU
NOS-1	MYjHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?				M3fqVGlEPTB;MUO0Mlc3PSEQvF2=	MXrTRW5ITVJ?
G-402	M{eyfGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7				Ml:3TWM2OD1zM{WuNlk2KM7:TR?=	MmLyV2FPT0WU
OAW-42	NY[3[Xg4T3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=				NXLjc2xZUUN3ME2xN\|cvQDV4IN88US=>	MVPTRW5ITVJ?
Ca-Ski	NHjiPW1Iem:5dHigTY5pcWKrdHnvckBCe3OjeR?=				NHKx[WxKSzVyPUGzPE45OzFizszN	NXTmdXZmW0GQR1XS
BHT-101	MojlS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?				M{jydmlEPTB;MUSwMlIxQCEQvF2=	M2GyT3NCVkeHUh?=
OVCAR-4	M4WxeGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7				M2TLcGlEPTB;MUSwMlc1QSEQvF2=	NIL2R4NUSU6JRWK=
Detroit562	M3HWd2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7				M1jLfWlEPTB;MUSxMlQ3PiEQvF2=	MUTTRW5ITVJ?
OCI-AML2	NYe3Z5FHT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=				NHzi[YFKSzVyPUG0NU42ODdizszN	M4m1e3NCVkeHUh?=
OE33	MXrHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?				Ml3tTWM2OD1zNEGuO\|k5KM7:TR?=	NU\MXo1rW0GQR1XS
YKG-1	MV3Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?				MYfJR\|UxRTF2Mj64PFkh\|ryP	MXvTRW5ITVJ?
CCF-STTG1	MoTGS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?				NVvQe5RsUUN3ME2xOFMvOzN2IN88US=>	NIDB[3FUSU6JRWK=
NCI-H810	M4\tcmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7				MWLJR\|UxRTF2Mz62PFch\|ryP	NEXFRWlUSU6JRWK=
SCC-25	MUjHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?				Mn\sTWM2OD1zNESuNFA2KM7:TR?=	MU\TRW5ITVJ?
HTC-C3	MUTHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?				MkDGTWM2OD1zNEWuNFc2KM7:TR?=	NIHVRXJUSU6JRWK=
G-401	M2HpTmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7				Ml72TWM2OD1zNEWuPFM2KM7:TR?=	NULofZBbW0GQR1XS
OMC-1	NIW5RmJIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=				NX\GZoZ2UUN3ME2xOFUvQTZ5IN88US=>	NG\4OndUSU6JRWK=
LK-2	MlnxS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?				MXvJR\|UxRTF2Nz6xOFMh\|ryP	NFzneXVUSU6JRWK=
SW13	MoDxS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?				Mn34TWM2OD1zNEeuNlU{KM7:TR?=	M3LpdXNCVkeHUh?=
BB49-HNC	NYO1Zo5ET3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=				M3HwO2lEPTB;MUS3MlQxPCEQvF2=	MlrIV2FPT0WU
DMS-114	NF7UN\|NIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=				MY\JR\|UxRTF2Nz60OFEh\|ryP	MYPTRW5ITVJ?
GCIY	M17ldGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7				NHyyOmZKSzVyPUG0O{44QTdizszN	MVLTRW5ITVJ?
GAMG	M1zwW2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7				MlPMTWM2OD1zNEiuNlQ4KM7:TR?=	MV7TRW5ITVJ?
KYSE-520	M3\uRmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7				NFixVFRKSzVyPUG0PE42PCEQvF2=	MY\TRW5ITVJ?
LB647-SCLC	MoLUS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?				MV;JR\|UxRTF2OD61OlIh\|ryP	MXPTRW5ITVJ?
639-V	NG\qWZhIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=				NHu2UYRKSzVyPUG0PE44ODVizszN	NYDvcYFrW0GQR1XS
TE-9	NHSxdVdIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=				NEjvUnlKSzVyPUG0PU41PDNizszN	MX;TRW5ITVJ?
Caov-3	MWfHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?				MmPoTWM2OD1zNEmuO\|E1KM7:TR?=	M3Hne3NCVkeHUh?=
L-540	MYHHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?				NX3JO2hDUUN3ME2xOFkvPzVizszN	NHXwSZFUSU6JRWK=
NCI-H748	MXzHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?				MULJR\|UxRTF3MD6yNFkh\|ryP	NX;6RVU2W0GQR1XS
GDM-1	MXLHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?				MkLvTWM2OD1zNUGuNVM2KM7:TR?=	NIji[WtUSU6JRWK=
GAK	MnvKS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?				M{CwcGlEPTB;MUWxMlM4PCEQvF2=	M17kSXNCVkeHUh?=
AsPC-1	MoL1S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?				NF6we3hKSzVyPUG1Nk44PjRizszN	M2O0eHNCVkeHUh?=
MDA-MB-361	M3jtS2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7				M4nidWlEPTB;MUWzMlE3PCEQvF2=	NH7IfFdUSU6JRWK=
TT	M{joS2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7				NUXZXYYzUUN3ME2xOVMvPDlizszN	MnX6V2FPT0WU
Calu-1	MkfjS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?				M4LMOWlEPTB;MUW0MlAxOyEQvF2=	M3r4[3NCVkeHUh?=
RERF-LC-MS	M3q5NWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7				MkTYTWM2OD1zNUSuO\|czKM7:TR?=	NHPzSmZUSU6JRWK=
DK-MG	NUHYc4Z{T3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=				MWPJR\|UxRTF3NT6xPFMh\|ryP	MkfBV2FPT0WU
CAL-120	MYrHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?				NHf2fI5KSzVyPUG1OU45OjFizszN	MUTTRW5ITVJ?
HCC1419	MmPzS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?				NHrQR45KSzVyPUG1Ok4xPzdizszN	MUHTRW5ITVJ?
DG-75	Mke2S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?				M1\X[WlEPTB;MUW2MlY6PCEQvF2=	MWnTRW5ITVJ?
HCC38	MkLGS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?				NXHTS5V[UUN3ME2xOVcvOzZ7IN88US=>	NXGwXZROW0GQR1XS
HCC70	M3vDW2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7				MmezTWM2OD1zNUmuNlQzKM7:TR?=	M3PycHNCVkeHUh?=
ES4	M2HGSGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7				NETyVG9KSzVyPUG1PU4{QTZizszN	MVnTRW5ITVJ?
NCI-H2052	MVXHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?				MXrJR\|UxRTF3OT61PFMh\|ryP	M1i4UXNCVkeHUh?=
EFO-27	MX3Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?				MXvJR\|UxRTF4MD61PFQh\|ryP	MnL6V2FPT0WU
CAL-62	NFm0NG9Iem:5dHigTY5pcWKrdHnvckBCe3OjeR?=				NInmOZJKSzVyPUG2Nk43OTNizszN	MkXWV2FPT0WU
CHP-212	MVzHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?				NGK4bIVKSzVyPUG2N{43OjZizszN	NGPmdWdUSU6JRWK=
AU565	NHW1[HdIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=				Mn2zTWM2OD1zNkOuOlQh\|ryP	NWqzW4NrW0GQR1XS
Ca9-22	NFLFeZBIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=				MY\JR\|UxRTF4ND6zNlEh\|ryP	MV;TRW5ITVJ?
EFO-21	NV75[YdUT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=				MlLwTWM2OD1zNkWuOFUh\|ryP	M17icXNCVkeHUh?=
KINGS-1	MVPHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?				NF24UoFKSzVyPUG2O{4{PTRizszN	M{OxbnNCVkeHUh?=
JVM-2	MYrHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?				NF7CW4JKSzVyPUG2O{41PTFizszN	MVvTRW5ITVJ?
OVCAR-5	NGrPOYdIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=				MmDBTWM2OD1zNkiuN\|A6KM7:TR?=	Mk\xV2FPT0WU
Calu-3	MmPsS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?				MXHJR\|UxRTF4OD6zNVEh\|ryP	M1qycnNCVkeHUh?=
CP66-MEL	MV3Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?				NFfpWGtKSzVyPUG2PE41OTVizszN	M2rqdnNCVkeHUh?=
KYSE-150	MmHqS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?				NUjrbo5YUUN3ME2xOlkvPjN4IN88US=>	M1r0UXNCVkeHUh?=
Daoy	MljvS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?				NVvW[opLUUN3ME2xOlkvQDlzIN88US=>	M4rN[HNCVkeHUh?=
HUTU-80	NFjQdnRIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=				M{K0[mlEPTB;MUexMlA{OiEQvF2=	MlT4V2FPT0WU
SW620	Ml\1S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?				MliyTWM2OD1zN{GuOVM2KM7:TR?=	M2fyVHNCVkeHUh?=
HuO-3N1	NUjURYdGT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=				NUXLelhNUUN3ME2xO\|IvOjd\|IN88US=>	NVnafIM1W0GQR1XS
HH	MY\Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?				MWrJR\|UxRTF5Mz64OFgh\|ryP	NXLk[oFrW0GQR1XS
ME-180	NU\YNoNyT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=				MYXJR\|UxRTF5ND6wNVYh\|ryP	MVTTRW5ITVJ?
SW756	M2HEN2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7				MUjJR\|UxRTF5ND64OlMh\|ryP	M1XybnNCVkeHUh?=
LNCaP-Clone-FGC	MnfZS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?				M1fsUGlEPTB;MUe1Mlg3OSEQvF2=	NFPvTZFUSU6JRWK=
YT	M4n0cWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7				MV\JR\|UxRTF5Nj6zPVkh\|ryP	MmjQV2FPT0WU
EW-3	MoDJS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?				MlHhTWM2OD1zN{[uOVU2KM7:TR?=	M3LhbHNCVkeHUh?=
COLO-741	MnXTS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?				NWXYV\|hRUUN3ME2xO\|cvPTZzIN88US=>	M1fsT3NCVkeHUh?=
SK-NEP-1	MXzHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?				MmT3TWM2OD1zN{euPFA3KM7:TR?=	NX;QeIxZW0GQR1XS
NB10	M4nZOWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7				NHvWT4dKSzVyPUG3O{45PDZizszN	NGSyPYZUSU6JRWK=
SF126	NXjv[VgyT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=				MUjJR\|UxRTF5OT60N\|Ih\|ryP	MXjTRW5ITVJ?
NCI-H522	M4HUfGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7				NHnt[HVKSzVyPUG4NU4xPTlizszN	MWPTRW5ITVJ?
PSN1	NWGxNGN4T3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=				M13QTmlEPTB;MUixMlY3KM7:TR?=	MmiyV2FPT0WU
GI-ME-N	M2fJWWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7				NFXLNnFKSzVyPUG4NU43PzJizszN	NWTzPVRxW0GQR1XS
SBC-5	NXjHc2g1T3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=				MkHUTWM2OD1zOEGuPVM1KM7:TR?=	M1\sVXNCVkeHUh?=
ONS-76	NWG2fo5wT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=				NWT1cFZvUUN3ME2xPFIvOzh5IN88US=>	Ml\4V2FPT0WU
LOUCY	MXfHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?				MnfvTWM2OD1zOEKuOlg5KM7:TR?=	M3P5R3NCVkeHUh?=
SN12C	NGX3XmhIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=				MUfJR\|UxRTF6Mj64Nlkh\|ryP	MYTTRW5ITVJ?
A427	M{LwSGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7				NXfINllHUUN3ME2xPFQvPjNzIN88US=>	MmXTV2FPT0WU
DOK	MVTHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?				NUDyVHQ1UUN3ME2xPFQvPjR\|IN88US=>	MXTTRW5ITVJ?
MDA-MB-415	NGC0TJpIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=				NX6yd3NlUUN3ME2xPFQvPjVzIN88US=>	NV3IeIpCW0GQR1XS
MRK-nu-1	NVLafZg{T3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=				NV7WU2hRUUN3ME2xPFQvQTd{IN88US=>	NXrrc\|ZjW0GQR1XS
LB2241-RCC	MkK5S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?				MnXVTWM2OD1zOEWuNVQ2KM7:TR?=	NFLrbIJUSU6JRWK=
NCI-H1563	NUL2XJZxT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=				MkLETWM2OD1zOEWuNlA6KM7:TR?=	NI\LfY1USU6JRWK=
MDA-MB-453	NHu4XZZIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=				M2ezTGlEPTB;MUi2Mlk1OSEQvF2=	NVraSWJZW0GQR1XS
MONO-MAC-6	NVO2eVlrT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=				M3vKZ2lEPTB;MUi3MlM6OiEQvF2=	MX7TRW5ITVJ?
CAPAN-1	NEnPeVNIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=				NWm2[I5JUUN3ME2xPFcvPDV\|IN88US=>	NYDsfolSW0GQR1XS
SK-LU-1	MYXHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?				MnP0TWM2OD1zOEiuOFI5KM7:TR?=	MUHTRW5ITVJ?
NCI-H1299	MkmxS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?				NEflfo9KSzVyPUG4PE44OTlizszN	M4DoNnNCVkeHUh?=
KG-1	MWTHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?				MVzJR\|UxRTF6OT63PVgh\|ryP	NWrXfHg1W0GQR1XS
ETK-1	MXvHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?				MmXqTWM2OD1zOUCuNVgyKM7:TR?=	NVjzSIQzW0GQR1XS
NCI-H838	MUPHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?				MlzXTWM2OD1zOUCuN\|Qh\|ryP	M1u3VXNCVkeHUh?=
HCE-4	MXnHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?				NF;SdppKSzVyPUG5NE46QTJizszN	MnrDV2FPT0WU
A2780	M3flSGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7				MmjnTWM2OD1zOUKuPFkyKM7:TR?=	NVzIVGNDW0GQR1XS
COLO-668	NWmzfYJoT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=				MVLJR\|UxRTF7Mz6xOVch\|ryP	NFSwPHdUSU6JRWK=
HGC-27	MV7Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?				NHTWXXFKSzVyPUG5OU42OzhizszN	MX\TRW5ITVJ?
SW1088	M3u5Smdzd3e2aDDJcohq[mm2aX;uJGF{e2G7				MYPJR\|UxRTF7NT62O\|ch\|ryP	MWjTRW5ITVJ?
KOSC-2	NFfvZVJIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=				NETQcWxKSzVyPUG5OU45OThizszN	MlXuV2FPT0WU
TE-1	Mn6yS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?				M4LQOmlEPTB;MUm2MlI3KM7:TR?=	Mnz1V2FPT0WU
SW780	M4i1VGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7				NV;kb4NtUUN3ME2xPVYvPzN2IN88US=>	MlLrV2FPT0WU
22RV1	NWTrR4xXT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=				M4DxZmlEPTB;MUm3MlQzPCEQvF2=	NVza[25DW0GQR1XS
IA-LM	NYLH[\|ZFT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=				MmTJTWM2OD1zOUeuPFIzKM7:TR?=	M1zTZXNCVkeHUh?=
TE-5	M1u1cmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7				MYjJR\|UxRTF7OD6wN\|Mh\|ryP	MVHTRW5ITVJ?
JVM-3	NVztVGRWT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=				NFnNVIFKSzVyPUG5PE41OTlizszN	M3vCTXNCVkeHUh?=
HT55	NI[2SlVIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=				NVH5PGFTUUN3ME2xPVkvOTl{IN88US=>	MXrTRW5ITVJ?
QIMR-WIL	Ml7TS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?				MkTZTWM2OD1{MECuNVE3KM7:TR?=	M17WenNCVkeHUh?=
SJRH30	M{fZbGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7				MmTyTWM2OD1{MECuOVE2KM7:TR?=	NFLmfpBUSU6JRWK=
COLO-679	M{i1S2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7				MnPuTWM2OD1{MECuPFU6KM7:TR?=	MVHTRW5ITVJ?
MDA-MB-231	NH7YTodIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=				NWDYZm9vUUN3ME2yNFAvQTB{IN88US=>	NX\PfWs5W0GQR1XS
MFM-223	NVL2RXR2T3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=				MYfJR\|UxRTJyMT61PFch\|ryP	NX\6blY2W0GQR1XS
MFE-280	M1z5Rmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7				MoX1TWM2OD1{MEGuPVYyKM7:TR?=	MmDvV2FPT0WU
LAMA-84	MY\Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?				NYHYU2RpUUN3ME2yNFIvODd\|IN88US=>	MoHIV2FPT0WU
LS-1034	NVjYeoZMT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=				MWTJR\|UxRTJyMj61OVMh\|ryP	MYDTRW5ITVJ?
NCI-H345	NXXPSHBsT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=				M3zX[GlEPTB;MkCzMlAzPyEQvF2=	NXLrb5oyW0GQR1XS
KYSE-70	NVr4NIhpT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=				MkHkTWM2OD1{MEOuPFc6KM7:TR?=	NW\WNpVMW0GQR1XS
EGI-1	M1z4TGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7				NWi4NVVRUUN3ME2yNFQvQDN\|IN88US=>	NIj4TJZUSU6JRWK=
RPMI-2650	NFXuSYVIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=				M2OzfWlEPTB;MkC1MlQ3PyEQvF2=	NVu3fVBxW0GQR1XS
NCI-H1651	NXmzOlBYT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=				NX\vW4JuUUN3ME2yNFYvPzNizszN	NHrRO2JUSU6JRWK=
HPAF-II	NHnvZ5JIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=				Mkj5TWM2OD1{MEmuOlcyKM7:TR?=	NGLIXo1USU6JRWK=
NUGC-3	NX3kWYh5T3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=				NHLqTGNKSzVyPUKwPU43PzhizszN	NF3mdo9USU6JRWK=
DJM-1	MVvHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?				MX7JR\|UxRTJyOT64PVch\|ryP	MYjTRW5ITVJ?
MHH-PREB-1	MVzHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?				M4HNVWlEPTB;MkGwMlM5OSEQvF2=	MYjTRW5ITVJ?
EW-18	NVLjcpV{T3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=				NEfQWmxKSzVyPUKxNE44PjNizszN	MnrDV2FPT0WU
BT-20	NEXkV4JIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=				MWTJR\|UxRTJzMD65PFYh\|ryP	NYjVW2dFW0GQR1XS
A431	MWPHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?				MkfHTWM2OD1{MUGuNlk6KM7:TR?=	M4TTNnNCVkeHUh?=
TCCSUP	M4\UUGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7				NFHId4NKSzVyPUKxNU42OzNizszN	NGHXO5dUSU6JRWK=
HO-1-N-1	Mn;zS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?				NVq0e45uUUN3ME2yNVIvQDl2IN88US=>	MlOyV2FPT0WU
NCI-H69	MlW4S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?				MYLJR\|UxRTJzND6xPFUh\|ryP	MlrZV2FPT0WU
ES7	MXnHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?				Mmr2TWM2OD1{MUSuPFc5KM7:TR?=	M1;pO3NCVkeHUh?=
C3A	MkPKS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?				Ml3zTWM2OD1{MUWuOVc2KM7:TR?=	NWHrS2wyW0GQR1XS
UACC-257	NVm1fHJGT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=				M3PVOWlEPTB;MkG3MlQ{KM7:TR?=	M4TFS3NCVkeHUh?=
DMS-153	Mkm0S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?				M{XMSmlEPTB;MkG3Mlg{PiEQvF2=	NXXwS\|R7W0GQR1XS
LB771-HNC	NHL2VZRIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=				NIPmSoVKSzVyPUKxO{45QTNizszN	MlnZV2FPT0WU
HOS	M335SWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7				MVjJR\|UxRTJzOD65JO69VQ>?	NGLLWnJUSU6JRWK=
THP-1	MojaS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?				NE\LOFJKSzVyPUKxPU43ODZizszN	NGPUfYpUSU6JRWK=
SCC-4	NWXXcnN7T3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=				M2[5cGlEPTB;MkKwMlM2OyEQvF2=	NInOOmFUSU6JRWK=
SCC-3	NUixOI9VT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=				NXq2cnZzUUN3ME2yNlAvPTd5IN88US=>	NVzVS4Q4W0GQR1XS
BC-1	MXjHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?				M3ntb2lEPTB;MkKwMlc6QSEQvF2=	M2nWcHNCVkeHUh?=
NCI-H1618	NYjFe2tLT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=				MYjJR\|UxRTJ{MT6wNVgh\|ryP	MortV2FPT0WU
CaR-1	NXXobmlbT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=				M33rU2lEPTB;MkKxMlI2OSEQvF2=	Mm\MV2FPT0WU
NCI-H1355	NEDVW\|BIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=				NGHndI5KSzVyPUKyNU4{PzdizszN	NYOzeGpxW0GQR1XS
NCI-H1993	M4O5c2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7				M4m4fGlEPTB;MkKyMlI{QSEQvF2=	Mo\vV2FPT0WU
NCI-H1623	MY\Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?				MVzJR\|UxRTJ{Mj6zPFkh\|ryP	M3nBPXNCVkeHUh?=
AGS	NFeyWGJIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=				NGTWUFFKSzVyPUKyNk42OjNizszN	M{TZW3NCVkeHUh?=
SAS	MmfFS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?				NH60Om5KSzVyPUKyN{44QTZizszN	NFe4eYdUSU6JRWK=
HCC1937	M1;wXmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7				MmK4TWM2OD1{MkSuN\|g6KM7:TR?=	NEPzbm5USU6JRWK=
NCI-H209	NX7OTVlST3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=				MojWTWM2OD1{Mk[uOVMh\|ryP	NUj0RZFbW0GQR1XS
NCI-H322M	NXPGVnZuT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=				M4PWSGlEPTB;MkK4MlAyQSEQvF2=	MnqwV2FPT0WU
CHL-1	NYP2WW4xT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=				NXP2bIZmUUN3ME2yNlgvOTNizszN	NH36eG9USU6JRWK=
NCI-H630	NUnqWFJLT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=				M3\xS2lEPTB;MkOyMlg6PyEQvF2=	MmC3V2FPT0WU
5637	NH6y[5RIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=				M3q0ZmlEPTB;MkOzMlAxOyEQvF2=	NEjGSGpUSU6JRWK=
MSTO-211H	NH:5d5hIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=				M3TtWmlEPTB;MkOzMlI4PiEQvF2=	MXXTRW5ITVJ?
YAPC	NV:zT453T3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=				NHHqXmpKSzVyPUKzOE4zPTNizszN	NFTxdmVUSU6JRWK=
SW1783	NHj4eFdIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=				MnjNTWM2OD1{M{SuOFEh\|ryP	MUHTRW5ITVJ?
GB-1	NFLYOphIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=				MX\JR\|UxRTJ\|NT6xO\|ch\|ryP	NVTySo0yW0GQR1XS
NCI-H520	M1W5VGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7				M4nvV2lEPTB;MkO1Mlc1OSEQvF2=	NFrUZZNUSU6JRWK=
NOMO-1	MlfGS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?				MnGzTWM2OD1{M{[uNFIh\|ryP	MlzDV2FPT0WU
NCCIT	MXjHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?				NHHGbJNKSzVyPUKzOk45PzNizszN	MVLTRW5ITVJ?
SW954	M4HJZmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7				MlToTWM2OD1{M{euPFY5KM7:TR?=	Mlm3V2FPT0WU
MOLT-4	NHvCNYhIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=				NGrWPXJKSzVyPUK0NU4zODlizszN	NYize5p6W0GQR1XS
EB2	MmnLS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?				NIPOXYJKSzVyPUK0NU46ODdizszN	MoXoV2FPT0WU
IPC-298	MofPS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?				Mo\1TWM2OD1{NEKuNFczKM7:TR?=	MnHjV2FPT0WU
GP5d	NEXOS5RIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=				NGjkbZNKSzVyPUK0Nk43OTZizszN	MnfFV2FPT0WU
HN	NFK2XFlIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=				NF\Ze2dKSzVyPUK0Nk46QTFizszN	M3\a[XNCVkeHUh?=
BFTC-909	NHnjPGxIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=				NWrpbmVPUUN3ME2yOFMvOTF6IN88US=>	MXXTRW5ITVJ?
ES5	M3TMR2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7				MVnJR\|UxRTJ2NT6wN\|gh\|ryP	Ml;hV2FPT0WU
SK-HEP-1	MlPuS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?				NGLCUWNKSzVyPUK0Ok4xPDNizszN	M2LVcHNCVkeHUh?=
T47D	NX:4W5ZbT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=				MXfJR\|UxRTJ2Nz6wNVMh\|ryP	NH:xdnBUSU6JRWK=
KYSE-510	NFTo[IhIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=				NVi0dJhJUUN3ME2yOFcvPTF5IN88US=>	NH;HWFJUSU6JRWK=
LC-1F	NWWyb2ZQT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=				MYLJR\|UxRTJ2OD6xOVYh\|ryP	M1TYfHNCVkeHUh?=
NCI-H1693	M1L4eGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7				MWPJR\|UxRTJ2OT60PVUh\|ryP	NGrTWmFUSU6JRWK=
COR-L23	NW\DdFFUT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=				M4TGbWlEPTB;MkWwMlQyOiEQvF2=	NVjmeFBqW0GQR1XS
NCI-H2228	MVnHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?				MoLBTWM2OD1{NUCuPFY1KM7:TR?=	MWHTRW5ITVJ?
NCI-H460	NH;GOnVIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=				M2HNZWlEPTB;MkWxMlQyPyEQvF2=	M4i1OXNCVkeHUh?=
TGBC1TKB	M3zCcmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7				NV\x[ItUUUN3ME2yOVIvQDd3IN88US=>	MVrTRW5ITVJ?
NCI-H1304	M{HUV2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7				NXuzVVRsUUN3ME2yOVMvOTV4IN88US=>	MUXTRW5ITVJ?
CAL-27	MV7Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?				MXTJR\|UxRTJ3Mz60PFUh\|ryP	NVuxXGU{W0GQR1XS
NCI-H187	MlO0S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?				M2\vVGlEPTB;MkW2Mlc3KM7:TR?=	NUfucGl1W0GQR1XS
HSC-2	NUjQU4V6T3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=				M13MS2lEPTB;MkW4MlU5PCEQvF2=	Mm\jV2FPT0WU
CAL-39	NGXkTVJIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=				NGDCT2JKSzVyPUK2NE4zPzJizszN	MmfwV2FPT0WU
HuH-7	NYrkVWtST3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=				NX7oU2k1UUN3ME2yOlAvQTl4IN88US=>	NIrvZlRUSU6JRWK=
MMAC-SF	MnLIS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?				NUPwbmlzUUN3ME2yOlEvOTl{IN88US=>	M1zUbnNCVkeHUh?=
VA-ES-BJ	NX\FOWV3T3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=				MVzJR\|UxRTJ4MT65NVgh\|ryP	MXXTRW5ITVJ?
A673	MnnhS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?				NGTPNWRKSzVyPUK2O{4xOjVizszN	NIO5PZhUSU6JRWK=
LU-165	NX;FUnpST3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=				MoT2TWM2OD1{NkeuPVQyKM7:TR?=	MoTSV2FPT0WU
CAL-12T	NY\Ub5pGT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=				MnXZTWM2OD1{NkiuN\|Y3KM7:TR?=	MU\TRW5ITVJ?
RD	NE\MU3dIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=				NGflWJlKSzVyPUK2PU4yOTlizszN	NIr1c3NUSU6JRWK=
MDA-MB-468	Mk\XS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?				MU\JR\|UxRTJ4OT6zN\|Mh\|ryP	M3;sc3NCVkeHUh?=
LN-405	Mn;rS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?				NUn6Z4lyUUN3ME2yOlkvPzB6IN88US=>	NULhOlZLW0GQR1XS
MHH-CALL-2	M1vwbWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7				NX3FbZU4UUN3ME2yOlkvQTJizszN	Mn;4V2FPT0WU
ES3	NF:0NFRIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=				NHnHS4NKSzVyPUK3NE4{PThizszN	M13kRXNCVkeHUh?=
SK-MEL-3	NGO4NlRIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=				MWDJR\|UxRTJ5NT60OVch\|ryP	M2nkVXNCVkeHUh?=
TE-10	M{f4Tmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7				M1f6UWlEPTB;Mke2MlQ{QSEQvF2=	NX7NWos2W0GQR1XS
BEN	MkTaS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?				NWrxNotqUUN3ME2yO\|YvPDZzIN88US=>	MXPTRW5ITVJ?
NB69	NFX3enlIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=				MoHETWM2OD1{N{euOFA2KM7:TR?=	MXfTRW5ITVJ?
CAMA-1	MXvHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?				NH;HbHZKSzVyPUK3PE4zPzlizszN	NEPQTpdUSU6JRWK=
NCI-H1792	M4[4VWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7				MWLJR\|UxRTJ5OT6xPFch\|ryP	NIfMRYNUSU6JRWK=
UACC-893	M3jVfGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7				MULJR\|UxRTJ6MD61OEDPxE1?	MmXkV2FPT0WU
TGW	MoPTS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?				MWPJR\|UxRTJ6Mz6wOVgh\|ryP	NV64XYJEW0GQR1XS
SH-4	M2ryUGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7				NWX0SldtUUN3ME2yPFMvOTJ\|IN88US=>	M{LUenNCVkeHUh?=
NCI-H2009	M2LVUmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7				NXHGV3F1UUN3ME2yPFMvQTV\|IN88US=>	NXnxTpd{W0GQR1XS
T84	M3TobWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7				NIXxbotKSzVyPUK4OE43PjVizszN	M1H3UXNCVkeHUh?=
EW-7	M372UWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7				MoHvTWM2OD1{OEWuNlMzKM7:TR?=	MYPTRW5ITVJ?
NCI-H1882	MV\Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?				NGTLRm5KSzVyPUK4Ok4xOzVizszN	MULTRW5ITVJ?
GMS-10	M4The2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7				MX\JR\|UxRTJ6Nz6xPFMh\|ryP	M2LC[nNCVkeHUh?=
HC-1	MX\Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?				NYT2VW1{UUN3ME2yPVAvPjB{IN88US=>	M37CPHNCVkeHUh?=
ABC-1	Ml7hS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?				MVvJR\|UxRTJ7MT6wOlkh\|ryP	M33GSXNCVkeHUh?=
HuP-T3	MnfCS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?				MmL2TWM2OD1{OUKuNVQ3KM7:TR?=	MnKyV2FPT0WU
HT-1197	M2nVZ2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7				NXK1bnZpUUN3ME2yPVIvQDd7IN88US=>	NVLqUIFbW0GQR1XS
SHP-77	MVvHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?				MlLNTWM2OD1{OUWuOVk4KM7:TR?=	MmPxV2FPT0WU
NCI-H524	NVnjcIhbT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=				MVLJR\|UxRTJ7NT63Olkh\|ryP	NXnDOW1TW0GQR1XS
SW626	NEP4bpBIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=				NGnSeIpKSzVyPUK5Ok4yOTVizszN	MorFV2FPT0WU
NCI-H2347	MV3Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?				MorsTWM2OD1{OU[uOFI2KM7:TR?=	MU\TRW5ITVJ?
U251	M3XCVWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7				Mor6TWM2OD1{OUiuOFM5KM7:TR?=	NFfrNJpUSU6JRWK=
RL95-2	NFuybYdIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=				NH;2UpZKSzVyPUOwNE4zPDdizszN	M3vYSHNCVkeHUh?=
C2BBe1	MX7Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?				NYnJVnVSUUN3ME2zNFAvPjlzIN88US=>	NGfL[WRUSU6JRWK=
HLE	NEC1ZWlIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=				NF3mXnFKSzVyPUOwNU45OThizszN	MmPIV2FPT0WU
COLO-680N	MoLIS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?				M2\wSGlEPTB;M{CyMlg6OyEQvF2=	M{G5XnNCVkeHUh?=
PLC-PRF-5	MkfkS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?				NUe3NHlMUUN3ME2zNFQvQTB5IN88US=>	MXvTRW5ITVJ?
SCC-15	MXzHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?				Mmf3TWM2OD1\|ME[uNFE4KM7:TR?=	MoPSV2FPT0WU
ECC12	NWS3UGFTT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=				M{jHW2lEPTB;M{GwMlI2PCEQvF2=	MUnTRW5ITVJ?
A388	M4my[2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7				MnX2TWM2OD1\|MUKuNFIzKM7:TR?=	NXfmUlViW0GQR1XS
ES1	NFj5WmdIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=				M3TkTGlEPTB;M{GyMlE5QSEQvF2=	NW\xW5ZkW0GQR1XS
J-RT3-T3-5	NXfkR4UyT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=				NInvUoJKSzVyPUOxN{42OjFizszN	M1zhWXNCVkeHUh?=
SNU-475	NYGwUXpOT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=				NGfJe\|hKSzVyPUOxOE4xQTFizszN	MlKyV2FPT0WU
647-V	NHTMeZJIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=				MoK1TWM2OD1\|MUSuOlc{KM7:TR?=	M3fzb3NCVkeHUh?=
IMR-5	Mn\vS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?				NETzS2lKSzVyPUOxOU4{QCEQvF2=	MXXTRW5ITVJ?
EW-24	NHvjT4ZIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=				NXTlZVA2UUN3ME2zNlAvODdizszN	NHPxRZhUSU6JRWK=
CAL-51	MmXIS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?				NVH5OlczUUN3ME2zNlEvPDB\|IN88US=>	MY\TRW5ITVJ?
HD-MY-Z	NIPwVlBIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=				MVzJR\|UxRTN{MT60NFkh\|ryP	MVzTRW5ITVJ?
EW-13	NXTBZo5HT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=				M4LiOGlEPTB;M{KyMlQzPCEQvF2=	MonQV2FPT0WU
SK-N-FI	NEXTcoZIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=				MVLJR\|UxRTN{Mj60OVIh\|ryP	NUO4UHpyW0GQR1XS
BHY	MV\Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?				Mn3ZTWM2OD1\|MkOuNVc2KM7:TR?=	MonIV2FPT0WU
OCUB-M	NWPVWoNNT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=				NV7VO\|F4UUN3ME2zNlMvPDN2IN88US=>	M1jQXnNCVkeHUh?=
HCC1954	NGfyUYpIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=				NIrFOpVKSzVyPUOyN{42QDJizszN	NULKUWdRW0GQR1XS
SK-MEL-24	NFHE[ZRIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=				M{HxVmlEPTB;M{K0MlEyOSEQvF2=	Ml7GV2FPT0WU
NTERA-S-cl-D1	NUO2PVN6T3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=				NYXFO4d2UUN3ME2zNlYvPDh7IN88US=>	NYfub5N[W0GQR1XS
SK-MEL-30	NGTYSphIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=				NGP6VWVKSzVyPUOyOk44OzhizszN	MX3TRW5ITVJ?
LS-123	Ml3rS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?				NH\ZdpNKSzVyPUOyPE4yPjRizszN	MkDOV2FPT0WU
SF268	NFvFPIxIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=				MXLJR\|UxRTN\|MD6yOlUh\|ryP	NFrmW5lUSU6JRWK=
BT-474	M1rxUmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7				NGfiU3VKSzVyPUOzNk41OThizszN	MmjuV2FPT0WU
NCI-H1522	NEHnepFIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=				MVXJR\|UxRTN\|ND6zN\|kh\|ryP	MVrTRW5ITVJ?
LC-2-ad	NF7TPIdIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=				M3v2RWlEPTB;M{O2MlU6OSEQvF2=	NIr3do1USU6JRWK=
LAN-6	M3f5PWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7				Mor3TWM2OD1\|M{[uPVc4KM7:TR?=	NYjSWokxW0GQR1XS
ARH-77	NH\ReHVIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=				M3TndGlEPTB;M{O3MlMzKM7:TR?=	NF\oSVNUSU6JRWK=
HuO9	MlHDS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?				NVu4e\|VGUUN3ME2zN\|cvPDdizszN	Mnr0V2FPT0WU
MLMA	NFr1SpdIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=				MYLJR\|UxRTN\|OD6xOVUh\|ryP	NHzTNXJUSU6JRWK=
Raji	MmriS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?				MVLJR\|UxRTN\|OD6zPEDPxE1?	NELoWnBUSU6JRWK=
GT3TKB	MUfHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?				MXjJR\|UxRTN\|OD60NVIh\|ryP	NFW4dIRUSU6JRWK=
NCI-H441	M2jFUWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7				NYjLb2VvUUN3ME2zOFEvPDF6IN88US=>	M{nFWnNCVkeHUh?=
NCI-H2030	M{fDR2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7				NXHqS\|J6UUN3ME2zOFEvPjB7IN88US=>	MnzYV2FPT0WU
VM-CUB-1	MmDHS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?				NFLTepVKSzVyPUO0Nk43OzZizszN	MVnTRW5ITVJ?
KP-4	NH[xSlZIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=				M3GzbGlEPTB;M{SzMlc{OyEQvF2=	NHPEOVdUSU6JRWK=
PF-382	NHzNflJIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=				MkW3TWM2OD1\|NESuOFIzKM7:TR?=	M4fKZnNCVkeHUh?=
NB13	MULHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?				NIO1dJJKSzVyPUO0OU42QCEQvF2=	MnfaV2FPT0WU
D-502MG	NFzUeFFIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=				NYjyNWM2UUN3ME2zOFUvQDF{IN88US=>	NEfxd4pUSU6JRWK=
CAL-54	NIf4V\|lIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=				MULJR\|UxRTN2NT64O\|kh\|ryP	MX;TRW5ITVJ?
DOHH-2	M2LXUmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7				MoXZTWM2OD1\|NE[uOlUh\|ryP	M1z2OHNCVkeHUh?=
SK-PN-DW	NFvVdINIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=				NFGwTIdKSzVyPUO0O{41OjZizszN	M1HsRXNCVkeHUh?=
NCI-H720	M1T4[mdzd3e2aDDJcohq[mm2aX;uJGF{e2G7				Mn;DTWM2OD1\|NEmuPFQ3KM7:TR?=	M2S4THNCVkeHUh?=
SW1990	MX3Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?				NYLIfW9{UUN3ME2zOVEvOjhizszN	M4jZXXNCVkeHUh?=
NCI-H2196	MVPHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?				M3yySWlEPTB;M{WyMlYzPCEQvF2=	NHzPRmZUSU6JRWK=
P30-OHK	MYnHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?				NHq5dlBKSzVyPUO1N{4xPjNizszN	NEjSdnlUSU6JRWK=
NCI-H358	NEnBPFlIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=				NWHS[nh7UUN3ME2zOVUvOzV4IN88US=>	MXzTRW5ITVJ?
CW-2	M3TmXmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7				MXnJR\|UxRTN3Nj61Nlkh\|ryP	NIO2eVBUSU6JRWK=
COLO-678	NVLGXolvT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=				NUO0RpZiUUN3ME2zOVcvQDZ\|IN88US=>	MoXMV2FPT0WU
NCI-H2126	NVzlNXlYT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=				NFmye2FKSzVyPUO1PE42OjFizszN	MXjTRW5ITVJ?
DMS-53	NXH2bVBHT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=				MY\JR\|UxRTN3OD63NVEh\|ryP	M{CyUHNCVkeHUh?=
NCI-H1838	M4G4emdzd3e2aDDJcohq[mm2aX;uJGF{e2G7				NFfrT29KSzVyPUO1PU46QDdizszN	MV\TRW5ITVJ?
SJSA-1	MV7Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?				M3HVXmlEPTB;M{[wMlk{QSEQvF2=	NYXjblNpW0GQR1XS
ChaGo-K-1	MUTHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?				MoDOTWM2OD1\|NkOuPVI1KM7:TR?=	M{XSbHNCVkeHUh?=
IST-SL2	NVS3b5NwT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=				Mn3VTWM2OD1\|N{KuPVI3KM7:TR?=	MmDrV2FPT0WU
U-266	MVrHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?				NELMZlZKSzVyPUO3N{4yOzJizszN	NULkPJdIW0GQR1XS
P31-FUJ	M1zZ[Gdzd3e2aDDJcohq[mm2aX;uJGF{e2G7				NHO4fnBKSzVyPUO3Ok46PjRizszN	Ml7OV2FPT0WU
HCC2157	NEHCOHZIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=				NG\OS2NKSzVyPUO3PE4yPjFizszN	M4jrW3NCVkeHUh?=
COR-L88	NGLRV3NIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=				MV;JR\|UxRTN6Mz62O\|ch\|ryP	NVnQW2dxW0GQR1XS
NCI-H596	NHviS4pIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=				NIfBSIVKSzVyPUO4OU4{PCEQvF2=	NF3lXlNUSU6JRWK=
GOTO	MX7Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?				NWrKcnFqUUN3ME2zPVAvPjRzIN88US=>	MlvqV2FPT0WU
NCI-H719	MVzHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?				NGS1c25KSzVyPUO5NU45QTNizszN	NXnPR4Y4W0GQR1XS
MN-60	NI\2ZnBIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=				NXzkR4tYUUN3ME2zPVMvQTR6IN88US=>	NH3zVo1USU6JRWK=
IST-SL1	NVfwRXhvT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=				Mkn1TWM2OD1\|OUSuOFA3KM7:TR?=	NGnyTHJUSU6JRWK=
TE-6	NFfKZZhIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=				M4fnS2lEPTB;M{m3MlI2PCEQvF2=	NYLJNGEzW0GQR1XS
SW962	M4nDeGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7				MoLhTWM2OD1\|OUiuOlkh\|ryP	MmnDV2FPT0WU
FADU	NWjNNXR5T3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=				MoLJTWM2OD12MEOuNFg{KM7:TR?=	MX3TRW5ITVJ?
ECC4	MojrS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?				M4nPdGlEPTB;NEC4MlQ2QCEQvF2=	M171bXNCVkeHUh?=
MES-SA	Moq2S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?				NW\1ZW9rUUN3ME20NFkvQThizszN	MmruV2FPT0WU
NCI-H716	MlzIS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?				MXnJR\|UxRTRzMD6wO\|Uh\|ryP	NIiwWm1USU6JRWK=
GR-ST	MYLHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?				NXT2WVZzUUN3ME20NVAvPDl5IN88US=>	MVPTRW5ITVJ?
KY821	Ml;YS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?				NGX4UZFKSzVyPUSxOE4xQDZizszN	NXSxOVllW0GQR1XS
NCI-H2141	MX\Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?				NGXJWoJKSzVyPUSyOE4{QDhizszN	MVTTRW5ITVJ?
MDA-MB-134-VI	M2T4Omdzd3e2aDDJcohq[mm2aX;uJGF{e2G7				M3HmU2lEPTB;NEOxMlA{OyEQvF2=	NVKyWmRZW0GQR1XS
RH-1	M13YTGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7				MlTZTWM2OD12M{WuNFkh\|ryP	NGrTfFNUSU6JRWK=
AM-38	MX3Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?				M3fpTmlEPTB;NEO4MlU1KM7:TR?=	NIDSe2VUSU6JRWK=
BL-70	MWrHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?				NULQ[5B5UUN3ME20N\|kvPDJ7IN88US=>	MV;TRW5ITVJ?
COLO-684	M1PVbmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7				M2jDbWlEPTB;NES4Mlg5QCEQvF2=	NEP4WI1USU6JRWK=
DMS-79	MoPNS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?				MYLJR\|UxRTR2OT62PEDPxE1?	MojnV2FPT0WU
EW-1	MoTsS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?				NEXtcopKSzVyPUS1Nk45QDhizszN	MmTwV2FPT0WU
MS-1	M2j2cWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7				M{\uTmlEPTB;NEW0MlM5PSEQvF2=	MULTRW5ITVJ?
A4-Fuk	M1LDN2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7				M2LxW2lEPTB;NEW0MlUxPyEQvF2=	M33Lc3NCVkeHUh?=
TALL-1	NXTxPYJ1T3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=				NXnob4hsUUN3ME20OVUvOjl5IN88US=>	NGnRdHNUSU6JRWK=
SCLC-21H	MmDKS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?				MYTJR\|UxRTR3NT62PVkh\|ryP	MXzTRW5ITVJ?
KMS-12-PE	NXOzVlVGT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=				NGj3RllKSzVyPUS1Ok45OjJizszN	MUTTRW5ITVJ?
TE-441-T	MV7Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?				MoXwTWM2OD12NUeuNVg3KM7:TR?=	NXXjbYFRW0GQR1XS
A3-KAW	NITpNHBIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=				MUTJR\|UxRTR4MD64OFEh\|ryP	MVXTRW5ITVJ?
NCI-H1092	NX[xNXdzT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=				MnvyTWM2OD12NkOuPVQ{KM7:TR?=	MV3TRW5ITVJ?
COR-L279	NWfYVFN3T3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=				NGfSOpVKSzVyPUS2OE45PDdizszN	M3jpR3NCVkeHUh?=
NCI-SNU-5	NFy1TXZIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=				NVXRcGJsUUN3ME20O\|IvOjhizszN	M{OxeHNCVkeHUh?=
JAR	MYTHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?				M2GyWGlEPTB;NEe0Mlc5QCEQvF2=	MVXTRW5ITVJ?
NCI-H446	NEPVPVRIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=				M{TVPWlEPTB;NEe3MlA5KM7:TR?=	NWnnXYNSW0GQR1XS
HDLM-2	M17hdmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7				NFTBR49KSzVyPUS4NE45PjlizszN	MYTTRW5ITVJ?
D-283MED	M{PQO2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7				MYDJR\|UxRTR6OD65NlQh\|ryP	MkfpV2FPT0WU
NCI-H1395	MkSyS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?				M2fweGlEPTB;NEi5MlAxPCEQvF2=	M{LTT3NCVkeHUh?=
RPMI-6666	MnOxS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?				MljpTWM2OD12OUGuN\|k5KM7:TR?=	MorIV2FPT0WU
CPC-N	MmLqS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?				M{jMdGlEPTB;NUCyMlA3OyEQvF2=	MmXIV2FPT0WU
EC-GI-10	NH3ueVRIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=				MXjJR\|UxRTVyMj6xOlkh\|ryP	NFGyWoxUSU6JRWK=
CA46	MnPaS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?				NVXDOYY4UUN3ME21NFQvPDB5IN88US=>	M{LqZXNCVkeHUh?=
EHEB	MX7Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?				NHrMR4dKSzVyPUWwO{4zODhizszN	MorTV2FPT0WU
RPMI-8402	NIjIO4FIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=				MYDJR\|UxRTVzMD6wNlEh\|ryP	MnP2V2FPT0WU
DU-4475	NHfqNGNIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=				NF7SPFFKSzVyPUWxNU4yODFizszN	M{[4ZnNCVkeHUh?=
P12-ICHIKAWA	M4[2TGdzd3e2aDDJcohq[mm2aX;uJGF{e2G7				M{nubmlEPTB;NUGxMlQyPiEQvF2=	NFrlb5RUSU6JRWK=
NCI-H1694	NXLQelQxT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=				M1X6cWlEPTB;NUGyMlQ{QSEQvF2=	MlfKV2FPT0WU
NCI-H2171	MXLHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?				Mo\nTWM2OD13MUKuO\|A2KM7:TR?=	MULTRW5ITVJ?
Mo-T	NGPlNphIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=				MoT2TWM2OD13MUWuNVE3KM7:TR?=	MnyxV2FPT0WU
HL-60	NI\uSIhIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=				NEDBSplKSzVyPUWyNk46OjRizszN	M2XJ[XNCVkeHUh?=
NCI-H1436	MV7Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?				NIrYWFZKSzVyPUWyN{4xPjRizszN	MWXTRW5ITVJ?
NCI-H510A	MVLHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?				MkLpTWM2OD13MkSuOlk3KM7:TR?=	NVrPV\|loW0GQR1XS
NCI-H2081	NUDBb2VTT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=				NGPTdmtKSzVyPUWyOU42OTNizszN	MlP5V2FPT0WU
NB5	MkDJS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?				M{HCTmlEPTB;NUK2MlQ{KM7:TR?=	M{OyN3NCVkeHUh?=
NCI-H2227	NGLUe2dIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=				NHnVUZNKSzVyPUWzNE4zPTRizszN	MnWxV2FPT0WU
HSC-4	Ml;YS5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?				MoW1TWM2OD13M{muNlk{KM7:TR?=	NH7mTWZUSU6JRWK=
RL	M1HNdmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7				MU\JR\|UxRTV2Mj60OFIh\|ryP	NEnQd5BUSU6JRWK=
EVSA-T	MUPHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?				MmfBTWM2OD13NEOuOlg1KM7:TR?=	NYPxW495W0GQR1XS
NCI-H889	NXfrVlR1T3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=				MknUTWM2OD13NEeuNlMh\|ryP	NWL3b49WW0GQR1XS
COLO-320-HSR	NVTGOoJ5T3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=				NHzUXZFKSzVyPUW1NU4{PSEQvF2=	Mo\tV2FPT0WU
EW-11	M1vFV2dzd3e2aDDJcohq[mm2aX;uJGF{e2G7				NE[4fnhKSzVyPUW1Nk4{QTlizszN	MYrTRW5ITVJ?
UACC-812	NGDLWoJIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=				M3n5W2lEPTB;NUW5MlM6OSEQvF2=	MnzWV2FPT0WU
CAL-148	NWPNZotGT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=				NETEUndKSzVyPUW2OU4xQDlizszN	MmW4V2FPT0WU
K052	MUPHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?				NHOzVZlKSzVyPUW3PU4zOTNizszN	MU\TRW5ITVJ?
L-428	NYi1O3RHT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=				NIXWWHBKSzVyPU[wNE43PzFizszN	NVfzeGZmW0GQR1XS
LP-1	M1:5VWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7				NV;P[GZJUUN3ME22NFMvPTh5IN88US=>	MXzTRW5ITVJ?
ML-2	MV\Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?				Mm[3TWM2OD14ME[uOVc6KM7:TR?=	NHrudGlUSU6JRWK=
KARPAS-45	M3LBbWdzd3e2aDDJcohq[mm2aX;uJGF{e2G7				NU\nfoNxUUN3ME22NVgvOjJzIN88US=>	NXjBW5FVW0GQR1XS
HT	M3znZmdzd3e2aDDJcohq[mm2aX;uJGF{e2G7				M2S5bGlEPTB;NkKyMlc5PSEQvF2=	NYPIdItIW0GQR1XS
NCI-H226	NXLYOmdJT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=				NFj6ZYhKSzVyPU[yPE4{PTNizszN	Ml24V2FPT0WU
L-363	MWrHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?				M2Hx[mlEPTB;NkS4MlA3PCEQvF2=	M2XKOXNCVkeHUh?=
IM-9	MV3Hdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?				NX3SZ4NoUUN3ME22OVEvPTRzIN88US=>	M3naNXNCVkeHUh?=
TUR	MUTHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?				MVjJR\|UxRTZ5MT6zNlIh\|ryP	NX\KU2ZMW0GQR1XS
NCI-SNU-16	MYHHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?				NXzZSHpUUUN3ME22PFAvPDZ{IN88US=>	NE\5OFlUSU6JRWK=
NCI-SNU-1	MYPHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?				M4TyUWlEPTB;NkmwMlE4OiEQvF2=	NW\LNVc5W0GQR1XS
U-87-MG	MXnHdo94fGhiSX7obYJqfGmxbjDBd5NigQ>?				MW\JR\|UxRTZ7ND61PFUh\|ryP	MkPSV2FPT0WU
KM-H2	NE\IdHlIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=				MV\JR\|UxRTZ7OT6wOVkh\|ryP	NWfxNWsxW0GQR1XS
DEL	NXnQfXRHT3Kxd4ToJGlvcGmkaYTpc44hSXO\|YYm=				NWP3S3d4UUN3ME23NFAvQDN6IN88US=>	NV;xdZp3W0GQR1XS
KARPAS-422	MnT2S5Jwf3SqIFnubIljcXSrb36gRZN{[Xl?				M1nCWGlEPTB;N{i5MlMyPSEQvF2=	MXrTRW5ITVJ?
BC-3	NIrvT5RIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=				NHf5bGJKSzVyPUiwOU4zODNizszN	NGLFdppUSU6JRWK=
NCI-H1155	NGTtZ2tIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=				MknqTWM2OD16MUiuNFU6KM7:TR?=	MYTTRW5ITVJ?
NCI-H1581	NHfQcnFIem:5dHigTY5pcWKrdHnvckBCe3OjeR?=				MXzJR\|UxRTlyMD6yN\|Eh\|ryP	MUfTRW5ITVJ?

... Click to View More Cell Line Experimental Data

Assay

Methods	Test Index	PMID
Western blot	Cleaved PARP / CD31 / VE-Cadherin / α-SMA / vimentin; PubMed: 30709379 J Exp Clin Cancer Res NCI-H460 cells were co-cultured with HUVECs in a 3D culture system, and then treated with 1 μM CHIR-99021, 10 μM or 20 μM Cisplatin, or a combination of both, for 24 h. Cells were harvested and immunoblotted with anti-cleaved PARP, anti-CD31, anti-VE-cadherin, anti-α-SMA, anti-vimentin, and anti-β-actin antibodies. CTNNB1; PubMed: 23993102 Cell Treatment with the GSK3β inhibitor CHIR-99021 led to increased levels of β-catenin in RKO and HT29 (non-mutant) cells. β-catenin; PubMed: 24165128 J Biol Chem HeLa cells were treated with 5 μm CHIR-99021 for the indicated times. The samples were analyzed by Western blot.	30709379 23993102 24165128
Growth inhibition assay	Cell viability; PubMed: 22039301 J Immunol HMC-1.2 cells were cultured in the absence or presence of GSK3β inhibitor (CHIR 99021, 3–30 µM) and viability cell count was assessed by trypan blue dye exclusion after 24 h, 48 h or 72 h. All data are presented as the mean ± SEM of three independent experiments conducted in triplicate. p < 0.05, p < 0.001* p < 0.0001*** vs vehicle treated control cells.	22039301
Immunofluorescence	SOX10 / EdU; PubMed: 28174705 Cell Mol Gastroenterol Hepatol Incorporation of EdU (white arrowheads) into SOX10+ ENS (enteric nervous system) cells with and without CHIR-99021. Oct3/4; PubMed: 24779365 BMC Res Notes Fluorescence micrographs showing the protein expression of Brachyury/Oct3/4 after a three day differentiation of ES-D3 cells with BIO (0.5 μM), SB-216763 (5 μM), CHIR-99021 (5 μM), or CHIR-98014 (1 μM). Nuclei were counterstained with DAPI (blue). The merge is shown in yellow. Original magnification 400x. Scale bar = 50 μm.	28174705 24779365

In vivo

Oral administration of CHIR-99021 at 30 mg/kg enhances glucose metabolism in a rodent model of type 2 diabetes, with a maximal plasma glucose reduction of nearly 150 mg/dl 3-4 hours after administration, while plasma insulin remains at or below control levels. Oral administration of CHIR-99021 at 16 or 48 mg/kg 1 hour before oral glucose challenges in ZDF rats significantly improves glucose tolerance with 14% and 33% reduction in plasma glucose at 16 mg/kg and 48 mg/kg, respectively, and the higher dose of CHIR-99021 also reduces hyperglycemia before the oral glucose challenge. ^[1] Administration of CHIR-99021 significantly augments hematopoietic repopulation in recipient mice transplanted with mouse or human hematopoietic stem cells (HSCs), suggesting that GSK-3 is a specific modulator of HSC activity. ^[4]

Protocol

Kinase Assay: ^[1]	+ Expand Cell-free kinase assays: Polypropylene 96-well plates are filled with 300 μL/well buffer (50 mM tris HCl, 10 mM MgCl₂, 1 mM EGTA, 1 mM dithiothreitol, 25 mM β-glycerophosphate, 1 mM NaF, 0.01% BSA, pH 7.5) containing 27 nM GSK-3α or 29 nM GSK-3β, and 0.5 μM biotin-CREB peptide substrate. Various concentrations of CHIR-99021 are added in 3.5 μL of DMSO, followed by 50 μL of ATP stock to yield a final concentration of 1 μM ATP in all cell-free assays. After incubation, triplicate 100-μL aliquots are transferred to Combiplate eight plates containing 100 μL/well 50 μM ATP and 20 mM EDTA. After 1 hour, the wells are rinsed five times with PBS, filled with 200 μL of scintillation fluid, sealed, left 30 minutes, and counted in a scintillation counter. All steps are performed at room temperature.
Cell Research: ^[3]	+ Expand Cell lines: INS-1E Concentrations: Dissolved in DMSO, final concentrations ~ 20 μM Incubation Time: 1, or 4 days Method: Cells are maintained for 24 hours in starvation medium (culture medium with only 5 mM glucose, 1% fetal calf serum). Then cells are exposed to various concentrations of CHIR-99021 for 1, or 4 days. Cell number is measured by staining of cellular DNA with CyQuant dye, which becomes fluorescent when bound to DNA. Fluorescence is measured after 30 minutes of incubation using the FLUOstar Optima reader. Cell replication is determined by BrdUrd incorporation. BrdUrd labeling solution is added to the medium for the last 4 hours before the cells are fixed using FixDenat solution and incubated with monoclonal anti-BrdUrd-POD antibodies. After substrate solution is added to each well, the light emission is measured in a microplate luminometer using the Analyst HT detection system. (Only for Reference)
Animal Research: ^[1]	+ Expand Animal Models: Female db/db mice or male ZDF rats with type 2 diabetes Formulation: Formulated as solutions in 20 mM citrate-buffered 15% Captisol or as fine suspensions in 0.5% carboxymethylcellulose. Dosages: ~48 mg/kg Administration: Orally (Only for Reference)

References

Solubility (25°C)

In vitro	DMSO	93 mg/mL (185.33 mM)
	Ethanol	2 mg/mL (3.98 mM)
	Water	Insoluble
In vivo	Add solvents to the product individually and in order(Data is from Selleck tests instead of citations): 5% DMSO+30% PEG 300+ddH2O For best results, use promptly after mixing.	24mg/mL

* Please note that Selleck tests the solubility of all compounds in-house, and the actual solubility may differ slightly from published values. This is normal and is due to slight batch-to-batch variations.

Chemical Information Download CHIR-99021 (CT99021) HCl SDF

Molecular Weight	501.8
Formula	C₂₂H₁₈Cl₂N_8.HCl
CAS No.	1797989-42-4
Storage	3 years -20°C powder
Storage	2 years -80°C in solvent
Synonyms	N/A

Bio Calculators

Molarity Calculator

Calculate the mass, volume or concentration required for a solution. The Selleck molarity calculator is based on the following equation:

Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

*When preparing stock solutions, please always use the batch-specific molecular weight of the product found on the via label and MSDS / COA (available on product pages).

Dilution Calculator

Calculate the dilution required to prepare a stock solution. The Selleck dilution calculator is based on the following equation:

Concentration _(start) x Volume _(start) = Concentration _(final) x Volume _(final)

This equation is commonly abbreviated as: C1V1 = C2V2 ( Input Output )

* When preparing stock solutions always use the batch-specific molecular weight of the product found on the vial label and MSDS / COA (available online).

The Serial Dilution Calculator Equation

Serial Dilutions
Concertration (start):
Dilution-folds:

Computed Result

C1=C0/X	C1:	LOG(C1):
C2=C1/X	C2:	LOG(C2):
C3=C2/X	C3:	LOG(C3):
C4=C3/X	C4:	LOG(C4):
C5=C4/X	C5:	LOG(C5):
C6=C5/X	C6:	LOG(C6):
C7=C6/X	C7:	LOG(C7):
C8=C7/X	C8:	LOG(C8):

Molecular Weight Calculator

Enter the chemical formula of a compound to calculate its molar mass and elemental composition:

Tip: Chemical formula is case sensitive. C10H16N2O2 c10h16n2o2

Instructions to calculate molar mass (molecular weight) of a chemical compound:

To calculate molar mass of a chemical compound, please enter its chemical formula and click 'Calculate'.

Definitions of molecular mass, molecular weight, molar mass and molar weight:

Molecular mass (molecular weight) is the mass of one molecule of a substance and is expressed in the unified atomic mass units (u). (1 u is equal to 1/12 the mass of one atom of carbon-12)
Molar mass (molar weight) is the mass of one mole of a substance and is expressed in g/mol.

Molarity Calculator

Tech Support

Answers to questions you may have can be found in the inhibitor handling instructions. Topics include how to prepare stock solutions, how to store inhibitors, and issues that need special attention for cell-based assays and animal experiments.

Handling Instructions

Tel: +1-832-582-8158 Ext:3

If you have any other enquiries, please leave a message.

Frequently Asked Questions

Question 1:
I recently purchased CHIR 99021 to inject mice intraperitoneally. The data sheet says using 10% captisol for in vivo use. Is it for IP injection? Or do you have other solutions to suggest to use for in vivo IP injection of CHIR 99021?
Answer:
The formulation of 15% Captisol is for oral gavage, and S2924 CHIR-99021 (CT99021) HCl in it is a suspension. S2924 CHIR-99021 (CT99021) HCl can be dissolved in 5% DMSO+30% PEG 300+ddH2O at 24mg/ml as a clear solution for IP injection.
Question 2:
How about the half-life of this compound? If it is necessary for daily treatment when the compound is used in long-term experiment?
Answer:
Please change the culture medium each day to add the new comound in it if the duration is more than 72h.
Question 3:
What is the difference between S2924 and S1263? Which one is better for differentiation?
Answer:
S1263 is the free base format of Chir-99021, while S2924 is the HCl salt format. They have the same biological activity but are slightly different in solubility.

GSK-3 Signaling Pathway Map

GSK-3 Inhibitors with Unique Features

Selective GSK-3 Inhibitor

TWS119 : GSK-3β-selective, IC50 of 30 nM.
Most Potent GSK-3 Inhibitor

CHIR-98014 : GSK-3α, IC50=0.65 nM; GSK-3β, IC50=0.58 nM.
GSK-3 Inhibitor in Clinical Trial

Tideglusib : Phase II for Alzheimer's disease.
Newest GSK-3 Inhibitor

AZD1080 : Orally active, brain permeable GSK3 inhibitor, inhibits human GSK3α and GSK3β with K_i of 6.9 nM and 31 nM, respectively.

Related GSK-3 Products

CHIR-99021 (CT99021) ^New

CHIR-99021 (CT99021) is a GSK-3α and GSK-3β inhibitor with IC50 of 10 nM and 6.7 nM, respectively. CHIR99201 does not exhibit cross-reactivity against cyclin-dependent kinases (CDKs) and shows a 350-fold selectivity toward GSK-3β compared to CDKs.
LY2090314 ^New

LY2090314 is a potent GSK-3 inhibitor for GSK-3α/β with IC50 of 1.5 nM/0.9 nM; may improve the efficacy of platinum-based chemotherapy regimens. LY2090314 is highly selective towards GSK3 as demonstrated by its fold selectivity relative to a large panel of kinases.
TDZD-8 ^New

TDZD-8 is a non-ATP competitive GSK-3β inhibitor with IC50 of 2 μM; minimal inhibitory effect observed on CDK1, casein kinase II, PKA and PKC.
TWS119

TWS119 is a GSK-3β inhibitor with IC50 of 30 nM in a cell-free assay; capable of inducing neuronal differentiation and may be useful to stem cell biology.
SB216763

SB216763 is a potent and selective GSK-3 inhibitor with IC50 of 34.3 nM for GSK-3α and equally effective at inhibiting human GSK-3β.
Tideglusib

Tideglusib is an irreversible, non ATP-competitive GSK-3β inhibitor with IC50 of 60 nM in a cell-free assay; fails to inhibit kinases with a Cys homologous to Cys-199 located in the active site. Phase 2.
CHIR-98014

CHIR-98014 is a potent GSK-3α/β inhibitor with IC50 of 0.65 nM/0.58 nM in cell-free assays, with the ability to distinguish GSK-3 from its closest homologs Cdc2 and ERK2.
BIO

BIO is a specific inhibitor of GSK-3 with IC50 of 5 nM for GSK-3α/β in a cell-free assay, shows >16-fold selectivity over CDK5, also a pan-JAK inhibitor.

Features:The first pharmacological agent shown to maintain self-renewal in human and mouse embryonic stem cells.
AR-A014418

AR-A014418 is an ATP-competitive, and selective GSK3β inhibitor with IC50 and K_i of 104 nM and 38 nM in cell-free assays, without significant inhibition on 26 other kinases tested.
IM-12

IM-12 is a selective GSK-3β inhibitor with IC50 of 53 nM, and also enhances canonical Wnt signalling.

Choose Your Country or Region

By Signaling Pathways

By product type

CHIR-99021 (CT99021) HCl

Cited by 101 Publications

Purity & Quality Control

Choose Selective GSK-3 Inhibitors

Biological Activity

Protocol

References

Solubility (25°C)

Chemical Information Download CHIR-99021 (CT99021) HCl SDF

Bio Calculators

Molarity Calculator

Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

Dilution Calculator

Concentration _(start) x Volume _(start) = Concentration _(final) x Volume _(final)

The Serial Dilution Calculator Equation

Serial Dilutions

Computed Result

Molecular Weight Calculator

Total Molecular Weight: g/mol

Instructions to calculate molar mass (molecular weight) of a chemical compound:

Definitions of molecular mass, molecular weight, molar mass and molar weight:

Molarity Calculator

Tech Support

Frequently Asked Questions

GSK-3 Signaling Pathway Map

GSK-3 Inhibitors with Unique Features

Related GSK-3 Products

Choose Your Country or Region

By Signaling Pathways

By product type

CHIR-99021 (CT99021) HCl

Cited by 101 Publications

Purity & Quality Control

Choose Selective GSK-3 Inhibitors

Biological Activity

Protocol

References

Solubility (25°C)

Chemical Information Download CHIR-99021 (CT99021) HCl SDF

Bio Calculators

Molarity Calculator

Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

Dilution Calculator

Concentration (start) x Volume (start) = Concentration (final) x Volume (final)

The Serial Dilution Calculator Equation

Serial Dilutions

Computed Result

Molecular Weight Calculator

Total Molecular Weight: g/mol

Instructions to calculate molar mass (molecular weight) of a chemical compound:

Definitions of molecular mass, molecular weight, molar mass and molar weight:

Molarity Calculator

Tech Support

Frequently Asked Questions

GSK-3 Signaling Pathway Map

GSK-3 Inhibitors with Unique Features

Related GSK-3 Products

Concentration _(start) x Volume _(start) = Concentration _(final) x Volume _(final)